Component
Sulforaphane / SFN, stereochemistry specified per study
Sulforaphane is a broccoli-derived isothiocyanate formed from glucoraphanin. Its exposure depends on myrosinase and microbial conversion; its effects involve electrophile sensing, glutathione metabolism and other targets. It is not an essential vitamin, and no sulforaphane-deficiency syndrome is established.
80 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Pretreatment reduced aflatoxin-DNA adducts; simultaneous exposure without pretreatment did not.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/20442190.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "130e0a3ab9cbabd496a64344ae8bfb9f98cccbf7521a64ec807f14b2259ceb69", "start_char": 0, "end_char": 1705, "text_sha256": "130e0a3ab9cbabd496a64344ae8bfb9f98cccbf7521a64ec807f14b2259ceb69"}
- experimental_model
- Primary human hepatocyte pretreatment and genotyping
- exposure
- Sulforaphane 10 or 50 micromolar for 48 hours before aflatoxin B1
- limitations
- Culture exposures are not ordinary plasma exposures; reduced CYP3A4 mRNA does not establish the direction of clinical drug interactions.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human hepatocyte cultures
- plain_language
- The time allowed for a cellular response mattered.
- primary_references
- [sulforaphane-p20442190] Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. (2010). https://pubmed.ncbi.nlm.nih.gov/20442190/ DOI: 10.1093/toxsci/kfq135
- tissue_or_cell_type
- Aflatoxin activation and DNA damage
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1243–1254
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Primary human hepatocyte pretreatment and genotyping · source_derived_draft · unverified_draft
### sulforaphane-aflatoxin-pretreatment Pretreatment reduced aflatoxin-DNA adducts; simultaneous exposure without pretreatment did not. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The time allowed for a cellular response mattered. organism: Human hepatocyte cultures tissue_or_cell_type: Aflatoxin activation and DNA damage experimental_model: Primary human hepatocyte pretreatment and genotyping limitations: Culture exposures are not ordinary plasma exposures; reduced CYP3A4 mRNA does not establish the direction of clinical drug interactions. exposure: Sulforaphane 10 or 50 micromolar for 48 hours before aflatoxin B1 evidence_span: {"source_cache": "artifacts/sulforaphane-research/20442190.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "130e0a3ab9cbabd496a64344ae8bfb9f98cccbf7521a64ec807f14b2259ceb69", "start_char": 0, "end_char": 1705, "text_sha256": "130e0a3ab9cbabd496a64344ae8bfb9f98cccbf7521a64ec807f14b2259ceb69"} [sulforaphane-p20442190] Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. (2010). https://pubmed.ncbi.nlm.nih.gov/20442190/ DOI: 10.1093/toxsci/kfq135
Complete structured claim and evidenceReduced phosphorylation of the AKT substrate beta-catenin at S552 indicated lower AKT output despite increased AKT T308/S473 phosphorylation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/31409554.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b", "start_char": 0, "end_char": 1778, "text_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b"}
- experimental_model
- Human cell experiments with CRISPR NRF2 deletion
- exposure
- Concentration- and time-dependent sulforaphane treatment
- limitations
- Preclinical cancer-cell signaling; AKT phosphorylation did not reliably represent catalytic output. Not a human longevity or autophagy trial.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human U2OS osteosarcoma cells and NRF2-knockout counterpart
- plain_language
- An activation marker and the enzyme output moved in different directions.
- primary_references
- [sulforaphane-p31409554] The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. (2021). https://pubmed.ncbi.nlm.nih.gov/31409554/ DOI: 10.1016/j.phymed.2019.153062
- tissue_or_cell_type
- HDAC6, AKT and mTOR signaling
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 658–669
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human cell experiments with CRISPR NRF2 deletion · source_derived_draft · unverified_draft
### sulforaphane-akt-output Reduced phosphorylation of the AKT substrate beta-catenin at S552 indicated lower AKT output despite increased AKT T308/S473 phosphorylation. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: An activation marker and the enzyme output moved in different directions. organism: Human U2OS osteosarcoma cells and NRF2-knockout counterpart tissue_or_cell_type: HDAC6, AKT and mTOR signaling experimental_model: Human cell experiments with CRISPR NRF2 deletion limitations: Preclinical cancer-cell signaling; AKT phosphorylation did not reliably represent catalytic output. Not a human longevity or autophagy trial. exposure: Concentration- and time-dependent sulforaphane treatment evidence_span: {"source_cache": "artifacts/sulforaphane-research/31409554.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b", "start_char": 0, "end_char": 1778, "text_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b"} [sulforaphane-p31409554] The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. (2021). https://pubmed.ncbi.nlm.nih.gov/31409554/ DOI: 10.1016/j.phymed.2019.153062
Complete structured claim and evidenceThe active group showed a 34% ABC-score reduction at 18 weeks, with a significant between-treatment comparison.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/25313065.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d6f39bcdb3d5d89fd9226e208c82da13d9f18fee2003a8c817c67da0e344fd44", "start_char": 0, "end_char": 1872, "text_sha256": "d6f39bcdb3d5d89fd9226e208c82da13d9f18fee2003a8c817c67da0e344fd44"}
- experimental_model
- Randomized double-blind placebo-controlled trial
- exposure
- Sulforaphane 50-150 micromol/day for 18 weeks, then four weeks off
- limitations
- Small male-only study; symptom-scale changes are not a cure and do not establish mechanism.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 44 males aged 13-27, 29 active and 15 placebo
- plain_language
- One early trial reported improvement in this symptom scale.
- primary_references
- [sulforaphane-p25313065] Sulforaphane treatment of autism spectrum disorder (ASD). (2014). https://pubmed.ncbi.nlm.nih.gov/25313065/ DOI: 10.1073/pnas.1416940111
- tissue_or_cell_type
- ABC and SRS behavioral ratings
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1334–1345
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled trial · source_derived_draft · unverified_draft
### sulforaphane-autism-abc-early The active group showed a 34% ABC-score reduction at 18 weeks, with a significant between-treatment comparison. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: One early trial reported improvement in this symptom scale. organism: Human, 44 males aged 13-27, 29 active and 15 placebo tissue_or_cell_type: ABC and SRS behavioral ratings experimental_model: Randomized double-blind placebo-controlled trial limitations: Small male-only study; symptom-scale changes are not a cure and do not establish mechanism. exposure: Sulforaphane 50-150 micromol/day for 18 weeks, then four weeks off evidence_span: {"source_cache": "artifacts/sulforaphane-research/25313065.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d6f39bcdb3d5d89fd9226e208c82da13d9f18fee2003a8c817c67da0e344fd44", "start_char": 0, "end_char": 1872, "text_sha256": "d6f39bcdb3d5d89fd9226e208c82da13d9f18fee2003a8c817c67da0e344fd44"} [sulforaphane-p25313065] Sulforaphane treatment of autism spectrum disorder (ASD). (2014). https://pubmed.ncbi.nlm.nih.gov/25313065/ DOI: 10.1073/pnas.1416940111
Complete structured claim and evidenceClinician-rated scales improved, whereas caregiver-rated scales did not significantly differ from placebo.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/36427174.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "82957fc566b0bccc87dd6f53d6ad61edfa3d5b0b99ba6f557628c68f53faf1cc", "start_char": 0, "end_char": 826, "text_sha256": "82957fc566b0bccc87dd6f53d6ad61edfa3d5b0b99ba6f557628c68f53faf1cc"}
- experimental_model
- Randomized double-blind multicenter trial
- exposure
- Twelve-week treatment comparison
- limitations
- Rater-dependent results need replication; do not select only the favorable scale.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 108 participants with ASD in China
- plain_language
- The trial did not give one consistent result across observers.
- primary_references
- [sulforaphane-p36427174] Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial. (2024). https://pubmed.ncbi.nlm.nih.gov/36427174/ DOI: 10.1007/s10803-022-05784-9
- tissue_or_cell_type
- Caregiver versus clinician outcome ratings
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1399–1410
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind multicenter trial · source_derived_draft · unverified_draft
### sulforaphane-autism-rater-difference Clinician-rated scales improved, whereas caregiver-rated scales did not significantly differ from placebo. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The trial did not give one consistent result across observers. organism: Human, 108 participants with ASD in China tissue_or_cell_type: Caregiver versus clinician outcome ratings experimental_model: Randomized double-blind multicenter trial limitations: Rater-dependent results need replication; do not select only the favorable scale. exposure: Twelve-week treatment comparison evidence_span: {"source_cache": "artifacts/sulforaphane-research/36427174.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "82957fc566b0bccc87dd6f53d6ad61edfa3d5b0b99ba6f557628c68f53faf1cc", "start_char": 0, "end_char": 826, "text_sha256": "82957fc566b0bccc87dd6f53d6ad61edfa3d5b0b99ba6f557628c68f53faf1cc"} [sulforaphane-p36427174] Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial. (2024). https://pubmed.ncbi.nlm.nih.gov/36427174/ DOI: 10.1007/s10803-022-05784-9
Complete structured claim and evidenceSRS scores fell 17% in the active group; scores on the measured scales moved toward baseline after stopping treatment.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/25313065.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d6f39bcdb3d5d89fd9226e208c82da13d9f18fee2003a8c817c67da0e344fd44", "start_char": 0, "end_char": 1872, "text_sha256": "d6f39bcdb3d5d89fd9226e208c82da13d9f18fee2003a8c817c67da0e344fd44"}
- experimental_model
- Randomized double-blind placebo-controlled trial
- exposure
- Sulforaphane 50-150 micromol/day for 18 weeks, then four weeks off
- limitations
- Small male-only study; symptom-scale changes are not a cure and do not establish mechanism.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 44 males aged 13-27, 29 active and 15 placebo
- plain_language
- The reported effect was not sustained unchanged after withdrawal.
- primary_references
- [sulforaphane-p25313065] Sulforaphane treatment of autism spectrum disorder (ASD). (2014). https://pubmed.ncbi.nlm.nih.gov/25313065/ DOI: 10.1073/pnas.1416940111
- tissue_or_cell_type
- ABC and SRS behavioral ratings
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1347–1358
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled trial · source_derived_draft · unverified_draft
### sulforaphane-autism-srs-early SRS scores fell 17% in the active group; scores on the measured scales moved toward baseline after stopping treatment. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The reported effect was not sustained unchanged after withdrawal. organism: Human, 44 males aged 13-27, 29 active and 15 placebo tissue_or_cell_type: ABC and SRS behavioral ratings experimental_model: Randomized double-blind placebo-controlled trial limitations: Small male-only study; symptom-scale changes are not a cure and do not establish mechanism. exposure: Sulforaphane 50-150 micromol/day for 18 weeks, then four weeks off evidence_span: {"source_cache": "artifacts/sulforaphane-research/25313065.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d6f39bcdb3d5d89fd9226e208c82da13d9f18fee2003a8c817c67da0e344fd44", "start_char": 0, "end_char": 1872, "text_sha256": "d6f39bcdb3d5d89fd9226e208c82da13d9f18fee2003a8c817c67da0e344fd44"} [sulforaphane-p25313065] Sulforaphane treatment of autism spectrum disorder (ASD). (2014). https://pubmed.ncbi.nlm.nih.gov/25313065/ DOI: 10.1073/pnas.1416940111
Complete structured claim and evidenceThe study found no significant clinical improvement on ADOS-2, ABC or SRS-2 in the younger-child cohort.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/36771424.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b571349cae03a080b09b387fa132d9f534133caef7a187be028370a9db48636e", "start_char": 0, "end_char": 1410, "text_sha256": "b571349cae03a080b09b387fa132d9f534133caef7a187be028370a9db48636e"}
- experimental_model
- Prospective randomized double-blind placebo-controlled study
- exposure
- Assessments at baseline, 18 and 36 weeks
- limitations
- Small sample with attrition; different age/formulation/endpoint context is retained rather than automatically classified as a contradiction.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, children aged 3-7; 40 randomized and 28 completed
- plain_language
- Later testing did not reproduce a clear benefit in this population.
- primary_references
- [sulforaphane-p36771424] Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study. (2023). https://pubmed.ncbi.nlm.nih.gov/36771424/ DOI: 10.3390/nu15030718
- tissue_or_cell_type
- ABC, SRS-2 and ADOS-2
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1386–1397
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Prospective randomized double-blind placebo-controlled study · source_derived_draft · unverified_draft
### sulforaphane-autism-younger-null The study found no significant clinical improvement on ADOS-2, ABC or SRS-2 in the younger-child cohort. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Later testing did not reproduce a clear benefit in this population. organism: Human, children aged 3-7; 40 randomized and 28 completed tissue_or_cell_type: ABC, SRS-2 and ADOS-2 experimental_model: Prospective randomized double-blind placebo-controlled study limitations: Small sample with attrition; different age/formulation/endpoint context is retained rather than automatically classified as a contradiction. exposure: Assessments at baseline, 18 and 36 weeks evidence_span: {"source_cache": "artifacts/sulforaphane-research/36771424.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b571349cae03a080b09b387fa132d9f534133caef7a187be028370a9db48636e", "start_char": 0, "end_char": 1410, "text_sha256": "b571349cae03a080b09b387fa132d9f534133caef7a187be028370a9db48636e"} [sulforaphane-p36771424] Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study. (2023). https://pubmed.ncbi.nlm.nih.gov/36771424/ DOI: 10.3390/nu15030718
Complete structured claim and evidenceSulforaphane did not disrupt the KEAP1-Nrf2 association in the tested interaction assays.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/15572695.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765", "start_char": 0, "end_char": 1484, "text_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765"}
- experimental_model
- Cell transfection, coimmunoprecipitation and ubiquitination assays
- exposure
- Sulforaphane or quinone stress; C151S KEAP1 comparison
- limitations
- The measured interaction is ubiquitin-ligase regulation; do not describe it as obligatory physical release of all bound Nrf2.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human protein constructs in mammalian cell systems
- plain_language
- Activating this pathway did not require complete separation of these proteins in the assay.
- primary_references
- [sulforaphane-p15572695] Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. (2004). https://pubmed.ncbi.nlm.nih.gov/15572695/ DOI: 10.1128/mcb.24.24.10941-10953.2004
- tissue_or_cell_type
- KEAP1-CUL3-RBX1 control of Nrf2
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 489–500
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell transfection, coimmunoprecipitation and ubiquitination assays · source_derived_draft · unverified_draft
### sulforaphane-binding-not-release Sulforaphane did not disrupt the KEAP1-Nrf2 association in the tested interaction assays. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Activating this pathway did not require complete separation of these proteins in the assay. organism: Human protein constructs in mammalian cell systems tissue_or_cell_type: KEAP1-CUL3-RBX1 control of Nrf2 experimental_model: Cell transfection, coimmunoprecipitation and ubiquitination assays limitations: The measured interaction is ubiquitin-ligase regulation; do not describe it as obligatory physical release of all bound Nrf2. exposure: Sulforaphane or quinone stress; C151S KEAP1 comparison evidence_span: {"source_cache": "artifacts/sulforaphane-research/15572695.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765", "start_char": 0, "end_char": 1484, "text_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765"} [sulforaphane-p15572695] Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. (2004). https://pubmed.ncbi.nlm.nih.gov/15572695/ DOI: 10.1128/mcb.24.24.10941-10953.2004
Complete structured claim and evidenceInflammatory measures and pulmonary function did not differ among trial groups.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/27832073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003", "start_char": 0, "end_char": 1709, "text_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003"}
- experimental_model
- Randomized double-blind placebo-controlled phase 2 trial
- exposure
- 25 or 150 micromol sulforaphane daily for four weeks
- limitations
- Absorption was documented; cell-based target engagement cannot be assumed after oral dosing in patients.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 89 COPD patients
- plain_language
- The short trial did not demonstrate a functional lung benefit.
- primary_references
- [sulforaphane-p27832073] Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. (2016). https://pubmed.ncbi.nlm.nih.gov/27832073/ DOI: 10.1371/journal.pone.0163716
- tissue_or_cell_type
- Alveolar macrophages, bronchial epithelium and pulmonary function
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1100–1111
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled phase 2 trial · source_derived_draft · unverified_draft
### sulforaphane-copd-function-null Inflammatory measures and pulmonary function did not differ among trial groups. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The short trial did not demonstrate a functional lung benefit. organism: Human, 89 COPD patients tissue_or_cell_type: Alveolar macrophages, bronchial epithelium and pulmonary function experimental_model: Randomized double-blind placebo-controlled phase 2 trial limitations: Absorption was documented; cell-based target engagement cannot be assumed after oral dosing in patients. exposure: 25 or 150 micromol sulforaphane daily for four weeks evidence_span: {"source_cache": "artifacts/sulforaphane-research/27832073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003", "start_char": 0, "end_char": 1709, "text_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003"} [sulforaphane-p27832073] Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. (2016). https://pubmed.ncbi.nlm.nih.gov/27832073/ DOI: 10.1371/journal.pone.0163716
Complete structured claim and evidenceNeither oral dose consistently induced the measured Nrf2 target genes despite detectable plasma metabolites.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/27832073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003", "start_char": 0, "end_char": 1709, "text_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003"}
- experimental_model
- Randomized double-blind placebo-controlled phase 2 trial
- exposure
- 25 or 150 micromol sulforaphane daily for four weeks
- limitations
- Absorption was documented; cell-based target engagement cannot be assumed after oral dosing in patients.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 89 COPD patients
- plain_language
- Reaching the bloodstream did not guarantee the intended lung-cell response.
- primary_references
- [sulforaphane-p27832073] Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. (2016). https://pubmed.ncbi.nlm.nih.gov/27832073/ DOI: 10.1371/journal.pone.0163716
- tissue_or_cell_type
- Alveolar macrophages, bronchial epithelium and pulmonary function
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1087–1098
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled phase 2 trial · source_derived_draft · unverified_draft
### sulforaphane-copd-target-null Neither oral dose consistently induced the measured Nrf2 target genes despite detectable plasma metabolites. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Reaching the bloodstream did not guarantee the intended lung-cell response. organism: Human, 89 COPD patients tissue_or_cell_type: Alveolar macrophages, bronchial epithelium and pulmonary function experimental_model: Randomized double-blind placebo-controlled phase 2 trial limitations: Absorption was documented; cell-based target engagement cannot be assumed after oral dosing in patients. exposure: 25 or 150 micromol sulforaphane daily for four weeks evidence_span: {"source_cache": "artifacts/sulforaphane-research/27832073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003", "start_char": 0, "end_char": 1709, "text_sha256": "cc345cf4434bd2d27451706ec614763c7be7562ac3e368f0e21b38c0f4d21003"} [sulforaphane-p27832073] Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. (2016). https://pubmed.ncbi.nlm.nih.gov/27832073/ DOI: 10.1371/journal.pone.0163716
Complete structured claim and evidenceSulforaphane alone did not change CYP3A activity in the cohort overall; a high-baseline subgroup showed increased midazolam exposure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/23153560.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e13099fede346485f6e468497ff2a4754fcae4d0203dde7f54fc9643c0599fec", "start_char": 0, "end_char": 1664, "text_sha256": "e13099fede346485f6e468497ff2a4754fcae4d0203dde7f54fc9643c0599fec"}
- experimental_model
- Three-arm randomized crossover trial
- exposure
- Rifampicin 300 mg/day, with or without sulforaphane 450 micromol/day for seven days; sulforaphane alone
- limitations
- Average null result does not exclude individual or other-drug interactions; high-baseline subgroup finding is not a dosing rule.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 24 healthy adults; humanized-PXR mouse parallel study
- plain_language
- An average null and an exploratory subgroup signal must both remain visible.
- primary_references
- [sulforaphane-p23153560] Sulforaphane is not an effective antagonist of the human pregnane X-receptor in vivo. (2013). https://pubmed.ncbi.nlm.nih.gov/23153560/ DOI: 10.1016/j.taap.2012.10.029
- tissue_or_cell_type
- CYP3A phenotyping with midazolam
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1269–1280
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Three-arm randomized crossover trial · source_derived_draft · unverified_draft
### sulforaphane-cyp3a4-alone-null Sulforaphane alone did not change CYP3A activity in the cohort overall; a high-baseline subgroup showed increased midazolam exposure. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: An average null and an exploratory subgroup signal must both remain visible. organism: Human, 24 healthy adults; humanized-PXR mouse parallel study tissue_or_cell_type: CYP3A phenotyping with midazolam experimental_model: Three-arm randomized crossover trial limitations: Average null result does not exclude individual or other-drug interactions; high-baseline subgroup finding is not a dosing rule. exposure: Rifampicin 300 mg/day, with or without sulforaphane 450 micromol/day for seven days; sulforaphane alone evidence_span: {"source_cache": "artifacts/sulforaphane-research/23153560.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e13099fede346485f6e468497ff2a4754fcae4d0203dde7f54fc9643c0599fec", "start_char": 0, "end_char": 1664, "text_sha256": "e13099fede346485f6e468497ff2a4754fcae4d0203dde7f54fc9643c0599fec"} [sulforaphane-p23153560] Sulforaphane is not an effective antagonist of the human pregnane X-receptor in vivo. (2013). https://pubmed.ncbi.nlm.nih.gov/23153560/ DOI: 10.1016/j.taap.2012.10.029
Complete structured claim and evidenceCoadministration did not prevent rifampicin-driven CYP3A induction; rifampicin alone lowered midazolam AUC by 70%.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/23153560.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e13099fede346485f6e468497ff2a4754fcae4d0203dde7f54fc9643c0599fec", "start_char": 0, "end_char": 1664, "text_sha256": "e13099fede346485f6e468497ff2a4754fcae4d0203dde7f54fc9643c0599fec"}
- experimental_model
- Three-arm randomized crossover trial
- exposure
- Rifampicin 300 mg/day, with or without sulforaphane 450 micromol/day for seven days; sulforaphane alone
- limitations
- Average null result does not exclude individual or other-drug interactions; high-baseline subgroup finding is not a dosing rule.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 24 healthy adults; humanized-PXR mouse parallel study
- plain_language
- The proposed receptor-blocking effect from laboratory work did not carry through in the human trial.
- primary_references
- [sulforaphane-p23153560] Sulforaphane is not an effective antagonist of the human pregnane X-receptor in vivo. (2013). https://pubmed.ncbi.nlm.nih.gov/23153560/ DOI: 10.1016/j.taap.2012.10.029
- tissue_or_cell_type
- CYP3A phenotyping with midazolam
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1256–1267
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Three-arm randomized crossover trial · source_derived_draft · unverified_draft
### sulforaphane-cyp3a4-rifampicin-null Coadministration did not prevent rifampicin-driven CYP3A induction; rifampicin alone lowered midazolam AUC by 70%. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The proposed receptor-blocking effect from laboratory work did not carry through in the human trial. organism: Human, 24 healthy adults; humanized-PXR mouse parallel study tissue_or_cell_type: CYP3A phenotyping with midazolam experimental_model: Three-arm randomized crossover trial limitations: Average null result does not exclude individual or other-drug interactions; high-baseline subgroup finding is not a dosing rule. exposure: Rifampicin 300 mg/day, with or without sulforaphane 450 micromol/day for seven days; sulforaphane alone evidence_span: {"source_cache": "artifacts/sulforaphane-research/23153560.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e13099fede346485f6e468497ff2a4754fcae4d0203dde7f54fc9643c0599fec", "start_char": 0, "end_char": 1664, "text_sha256": "e13099fede346485f6e468497ff2a4754fcae4d0203dde7f54fc9643c0599fec"} [sulforaphane-p23153560] Sulforaphane is not an effective antagonist of the human pregnane X-receptor in vivo. (2013). https://pubmed.ncbi.nlm.nih.gov/23153560/ DOI: 10.1016/j.taap.2012.10.029
Complete structured claim and evidenceSulforaphane strongly reduced CYP3A4 mRNA in primary human hepatocytes without inducing GSTM1 or GSTT1 expression.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/20442190.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "130e0a3ab9cbabd496a64344ae8bfb9f98cccbf7521a64ec807f14b2259ceb69", "start_char": 0, "end_char": 1705, "text_sha256": "130e0a3ab9cbabd496a64344ae8bfb9f98cccbf7521a64ec807f14b2259ceb69"}
- experimental_model
- Primary human hepatocyte pretreatment and genotyping
- exposure
- Sulforaphane 10 or 50 micromolar for 48 hours before aflatoxin B1
- limitations
- Culture exposures are not ordinary plasma exposures; reduced CYP3A4 mRNA does not establish the direction of clinical drug interactions.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human hepatocyte cultures
- plain_language
- Suppressed activation machinery, rather than increased GST expression, accompanied the response.
- primary_references
- [sulforaphane-p20442190] Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. (2010). https://pubmed.ncbi.nlm.nih.gov/20442190/ DOI: 10.1093/toxsci/kfq135
- tissue_or_cell_type
- Aflatoxin activation and DNA damage
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1230–1241
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Primary human hepatocyte pretreatment and genotyping · source_derived_draft · unverified_draft
### sulforaphane-cyp3a4-transcription Sulforaphane strongly reduced CYP3A4 mRNA in primary human hepatocytes without inducing GSTM1 or GSTT1 expression. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Suppressed activation machinery, rather than increased GST expression, accompanied the response. organism: Human hepatocyte cultures tissue_or_cell_type: Aflatoxin activation and DNA damage experimental_model: Primary human hepatocyte pretreatment and genotyping limitations: Culture exposures are not ordinary plasma exposures; reduced CYP3A4 mRNA does not establish the direction of clinical drug interactions. exposure: Sulforaphane 10 or 50 micromolar for 48 hours before aflatoxin B1 evidence_span: {"source_cache": "artifacts/sulforaphane-research/20442190.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "130e0a3ab9cbabd496a64344ae8bfb9f98cccbf7521a64ec807f14b2259ceb69", "start_char": 0, "end_char": 1705, "text_sha256": "130e0a3ab9cbabd496a64344ae8bfb9f98cccbf7521a64ec807f14b2259ceb69"} [sulforaphane-p20442190] Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. (2010). https://pubmed.ncbi.nlm.nih.gov/20442190/ DOI: 10.1093/toxsci/kfq135
Complete structured claim and evidenceSulforaphane increased G6PD expression in the fibroblast study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/30595796.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274", "start_char": 0, "end_char": 2097, "text_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274"}
- experimental_model
- Replicative culture and metabolic/gene-expression measurements
- exposure
- Sulforaphane treatment during serial culture
- limitations
- Cell-culture senescence is not human longevity; expression is not necessarily flux.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MRC-5 and BJ fibroblasts
- plain_language
- The response includes machinery connected to the cellular reducing-power supply.
- primary_references
- [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
- tissue_or_cell_type
- Glucose handling, antioxidant response and senescence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 879–890
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Replicative culture and metabolic/gene-expression measurements · source_derived_draft · unverified_draft
### sulforaphane-g6pd-expression Sulforaphane increased G6PD expression in the fibroblast study. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response includes machinery connected to the cellular reducing-power supply. organism: Human MRC-5 and BJ fibroblasts tissue_or_cell_type: Glucose handling, antioxidant response and senescence experimental_model: Replicative culture and metabolic/gene-expression measurements limitations: Cell-culture senescence is not human longevity; expression is not necessarily flux. exposure: Sulforaphane treatment during serial culture evidence_span: {"source_cache": "artifacts/sulforaphane-research/30595796.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274", "start_char": 0, "end_char": 2097, "text_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274"} [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
Complete structured claim and evidenceSulforaphane increased GCLM gene expression in early-passage nonsenescent MRC-5 fibroblasts.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/30595796.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13f25a5ca61ca9bdf80d4b24878682c90b414a5718a73b6a5b86ff20a9673279", "start_char": 14986, "end_char": 15205, "text_sha256": "c8a5b844826129e5cff61e4e19c0eb34f04a29a8feb8ced52a567eae1585d935"}
- experimental_model
- Replicative culture and metabolic/gene-expression measurements
- exposure
- Sulforaphane treatment during serial culture
- limitations
- Cell-culture senescence is not human longevity; expression is not necessarily flux.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MRC-5 and BJ fibroblasts
- plain_language
- The response includes this separately identified defense-system protein.
- primary_references
- [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
- tissue_or_cell_type
- Glucose handling, antioxidant response and senescence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 931–942
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Replicative culture and metabolic/gene-expression measurements · source_derived_draft · unverified_draft
### sulforaphane-gclm-induction Sulforaphane increased GCLM gene expression in early-passage nonsenescent MRC-5 fibroblasts. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response includes this separately identified defense-system protein. organism: Human MRC-5 and BJ fibroblasts tissue_or_cell_type: Glucose handling, antioxidant response and senescence experimental_model: Replicative culture and metabolic/gene-expression measurements limitations: Cell-culture senescence is not human longevity; expression is not necessarily flux. exposure: Sulforaphane treatment during serial culture evidence_span: {"source_cache": "artifacts/sulforaphane-research/30595796.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13f25a5ca61ca9bdf80d4b24878682c90b414a5718a73b6a5b86ff20a9673279", "start_char": 14986, "end_char": 15205, "text_sha256": "c8a5b844826129e5cff61e4e19c0eb34f04a29a8feb8ced52a567eae1585d935"} [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
Complete structured claim and evidenceSulforaphane increased GSR gene expression in early-passage nonsenescent MRC-5 fibroblasts.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/30595796.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13f25a5ca61ca9bdf80d4b24878682c90b414a5718a73b6a5b86ff20a9673279", "start_char": 14986, "end_char": 15205, "text_sha256": "c8a5b844826129e5cff61e4e19c0eb34f04a29a8feb8ced52a567eae1585d935"}
- experimental_model
- Replicative culture and metabolic/gene-expression measurements
- exposure
- Sulforaphane treatment during serial culture
- limitations
- Cell-culture senescence is not human longevity; expression is not necessarily flux.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MRC-5 and BJ fibroblasts
- plain_language
- The response includes this separately identified defense-system protein.
- primary_references
- [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
- tissue_or_cell_type
- Glucose handling, antioxidant response and senescence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 944–955
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Replicative culture and metabolic/gene-expression measurements · source_derived_draft · unverified_draft
### sulforaphane-gsr-induction Sulforaphane increased GSR gene expression in early-passage nonsenescent MRC-5 fibroblasts. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response includes this separately identified defense-system protein. organism: Human MRC-5 and BJ fibroblasts tissue_or_cell_type: Glucose handling, antioxidant response and senescence experimental_model: Replicative culture and metabolic/gene-expression measurements limitations: Cell-culture senescence is not human longevity; expression is not necessarily flux. exposure: Sulforaphane treatment during serial culture evidence_span: {"source_cache": "artifacts/sulforaphane-research/30595796.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13f25a5ca61ca9bdf80d4b24878682c90b414a5718a73b6a5b86ff20a9673279", "start_char": 14986, "end_char": 15205, "text_sha256": "c8a5b844826129e5cff61e4e19c0eb34f04a29a8feb8ced52a567eae1585d935"} [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
Complete structured claim and evidenceParallel differentiated Caco-2 experiments assigned GSTA1 induction to sulforaphane; perfusion with mixed extract increased GSTA1 mRNA 2.0-fold.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/12756216.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af", "start_char": 0, "end_char": 1816, "text_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af"}
- experimental_model
- Human jejunal perfusion and parallel Caco-2 experiments
- exposure
- Dietary-concentration onion/broccoli extract perfusion
- limitations
- Human perfusion used a mixture; isolated Caco-2 comparisons help distinguish components. Local permeability is not systemic oral bioavailability.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human intestinal segment and human intestinal cell line
- plain_language
- The mixture and the isolated-component experiment provide different levels of attribution.
- primary_references
- [sulforaphane-p12756216] Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. (2003). https://pubmed.ncbi.nlm.nih.gov/12756216/ DOI: 10.1124/dmd.31.6.805
- tissue_or_cell_type
- Absorption, luminal return and gene expression
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 411–422
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human jejunal perfusion and parallel Caco-2 experiments · source_derived_draft · unverified_draft
### sulforaphane-gsta1-induction Parallel differentiated Caco-2 experiments assigned GSTA1 induction to sulforaphane; perfusion with mixed extract increased GSTA1 mRNA 2.0-fold. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The mixture and the isolated-component experiment provide different levels of attribution. organism: Human intestinal segment and human intestinal cell line tissue_or_cell_type: Absorption, luminal return and gene expression experimental_model: Human jejunal perfusion and parallel Caco-2 experiments limitations: Human perfusion used a mixture; isolated Caco-2 comparisons help distinguish components. Local permeability is not systemic oral bioavailability. exposure: Dietary-concentration onion/broccoli extract perfusion evidence_span: {"source_cache": "artifacts/sulforaphane-research/12756216.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af", "start_char": 0, "end_char": 1816, "text_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af"} [sulforaphane-p12756216] Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. (2003). https://pubmed.ncbi.nlm.nih.gov/12756216/ DOI: 10.1124/dmd.31.6.805
Complete structured claim and evidenceHDAC6 protein decreased early during treatment and HDAC6 transcript was suppressed after 48 hours.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/25307283.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc736d6c2f2dc6c4026bdad0a5835d69ed094775076a2c1606f47020e6783331", "start_char": 0, "end_char": 1504, "text_sha256": "cc736d6c2f2dc6c4026bdad0a5835d69ed094775076a2c1606f47020e6783331"}
- experimental_model
- Matched cell-type and time-course comparison
- exposure
- Sulforaphane exposure; serum and time-course comparisons
- limitations
- Activity assays, protein abundance and substrate acetylation are distinct endpoints; mechanism of their divergence was not established. Erratum PMID 27271518 adds an omitted funding acknowledgment without revising these results.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HaCaT keratinocytes and HCT116 colon cancer cells
- plain_language
- Protein abundance and catalytic activity must be recorded separately.
- primary_references
- [sulforaphane-p25307283] The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses. (2015). https://pubmed.ncbi.nlm.nih.gov/25307283/ DOI: 10.1002/mc.22224
- tissue_or_cell_type
- HDAC activity, protein levels and target acetylation
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 619–630
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Matched cell-type and time-course comparison · source_derived_draft · unverified_draft
### sulforaphane-hdac6-abundance HDAC6 protein decreased early during treatment and HDAC6 transcript was suppressed after 48 hours. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Protein abundance and catalytic activity must be recorded separately. organism: Human HaCaT keratinocytes and HCT116 colon cancer cells tissue_or_cell_type: HDAC activity, protein levels and target acetylation experimental_model: Matched cell-type and time-course comparison limitations: Activity assays, protein abundance and substrate acetylation are distinct endpoints; mechanism of their divergence was not established. Erratum PMID 27271518 adds an omitted funding acknowledgment without revising these results. exposure: Sulforaphane exposure; serum and time-course comparisons evidence_span: {"source_cache": "artifacts/sulforaphane-research/25307283.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc736d6c2f2dc6c4026bdad0a5835d69ed094775076a2c1606f47020e6783331", "start_char": 0, "end_char": 1504, "text_sha256": "cc736d6c2f2dc6c4026bdad0a5835d69ed094775076a2c1606f47020e6783331"} [sulforaphane-p25307283] The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses. (2015). https://pubmed.ncbi.nlm.nih.gov/25307283/ DOI: 10.1002/mc.22224
Complete structured claim and evidenceSulforaphane inhibited cytoplasmic HDAC6 activity in the U2OS study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/31409554.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b", "start_char": 0, "end_char": 1778, "text_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b"}
- experimental_model
- Human cell experiments with CRISPR NRF2 deletion
- exposure
- Concentration- and time-dependent sulforaphane treatment
- limitations
- Preclinical cancer-cell signaling; AKT phosphorylation did not reliably represent catalytic output. Not a human longevity or autophagy trial.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human U2OS osteosarcoma cells and NRF2-knockout counterpart
- plain_language
- This experiment identifies a particular HDAC isoform.
- primary_references
- [sulforaphane-p31409554] The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. (2021). https://pubmed.ncbi.nlm.nih.gov/31409554/ DOI: 10.1016/j.phymed.2019.153062
- tissue_or_cell_type
- HDAC6, AKT and mTOR signaling
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 645–656
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human cell experiments with CRISPR NRF2 deletion · source_derived_draft · unverified_draft
### sulforaphane-hdac6-activity Sulforaphane inhibited cytoplasmic HDAC6 activity in the U2OS study. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: This experiment identifies a particular HDAC isoform. organism: Human U2OS osteosarcoma cells and NRF2-knockout counterpart tissue_or_cell_type: HDAC6, AKT and mTOR signaling experimental_model: Human cell experiments with CRISPR NRF2 deletion limitations: Preclinical cancer-cell signaling; AKT phosphorylation did not reliably represent catalytic output. Not a human longevity or autophagy trial. exposure: Concentration- and time-dependent sulforaphane treatment evidence_span: {"source_cache": "artifacts/sulforaphane-research/31409554.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b", "start_char": 0, "end_char": 1778, "text_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b"} [sulforaphane-p31409554] The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. (2021). https://pubmed.ncbi.nlm.nih.gov/31409554/ DOI: 10.1016/j.phymed.2019.153062
Complete structured claim and evidenceSulforaphane lowered expression of key gluconeogenic enzymes in the hepatic-cell experiments.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"}
- experimental_model
- Network-guided preclinical work with a human intervention
- exposure
- Sulforaphane in the preclinical hepatic-cell arm
- limitations
- Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Experimental hepatic cells; distinct from the human intervention
- plain_language
- The machinery for making new glucose was reduced.
- primary_references
- [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
- tissue_or_cell_type
- Hepatic-cell experiments
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1126–1137
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Network-guided preclinical work with a human intervention · source_derived_draft · unverified_draft
### sulforaphane-hepatic-enzymes Sulforaphane lowered expression of key gluconeogenic enzymes in the hepatic-cell experiments. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The machinery for making new glucose was reduced. organism: Experimental hepatic cells; distinct from the human intervention tissue_or_cell_type: Hepatic-cell experiments experimental_model: Network-guided preclinical work with a human intervention limitations: Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed. exposure: Sulforaphane in the preclinical hepatic-cell arm evidence_span: {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"} [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
Complete structured claim and evidenceSulforaphane suppressed glucose production from hepatic cells in the preclinical component of the study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"}
- experimental_model
- Network-guided preclinical work with a human intervention
- exposure
- Sulforaphane in the preclinical hepatic-cell arm
- limitations
- Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Experimental hepatic cells; distinct from the human intervention
- plain_language
- This supplies a possible mechanism for the glucose-control research.
- primary_references
- [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
- tissue_or_cell_type
- Hepatic-cell experiments
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1139–1150
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Network-guided preclinical work with a human intervention · source_derived_draft · unverified_draft
### sulforaphane-hepatic-glucose Sulforaphane suppressed glucose production from hepatic cells in the preclinical component of the study. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: This supplies a possible mechanism for the glucose-control research. organism: Experimental hepatic cells; distinct from the human intervention tissue_or_cell_type: Hepatic-cell experiments experimental_model: Network-guided preclinical work with a human intervention limitations: Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed. exposure: Sulforaphane in the preclinical hepatic-cell arm evidence_span: {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"} [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
Complete structured claim and evidenceIn the hepatic-cell experiments, sulforaphane promoted NRF2 nuclear translocation in the mechanism linked to reduced glucose production.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"}
- experimental_model
- Network-guided preclinical work with a human intervention
- exposure
- Sulforaphane in the preclinical hepatic-cell arm
- limitations
- Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Experimental hepatic cells; distinct from the human intervention
- plain_language
- The glucose-production mechanism was studied in cells, separately from patient outcomes.
- primary_references
- [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
- tissue_or_cell_type
- Hepatic-cell experiments
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1113–1124
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Network-guided preclinical work with a human intervention · source_derived_draft · unverified_draft
### sulforaphane-hepatic-nrf2 In the hepatic-cell experiments, sulforaphane promoted NRF2 nuclear translocation in the mechanism linked to reduced glucose production. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The glucose-production mechanism was studied in cells, separately from patient outcomes. organism: Experimental hepatic cells; distinct from the human intervention tissue_or_cell_type: Hepatic-cell experiments experimental_model: Network-guided preclinical work with a human intervention limitations: Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed. exposure: Sulforaphane in the preclinical hepatic-cell arm evidence_span: {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"} [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
Complete structured claim and evidenceThe study reported sulforaphane cytotoxicity IC50 values of 25.1 micromolar in hepatocytes and 56.4 micromolar in HepG2 cells alongside lower-exposure protective experiments.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/25683399.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bfaef8428737a984f51d1c91e9f6dddaf1d40a19c8ced9ddd7f6a222a65e450e", "start_char": 0, "end_char": 1707, "text_sha256": "bfaef8428737a984f51d1c91e9f6dddaf1d40a19c8ced9ddd7f6a222a65e450e"}
- experimental_model
- Enzyme induction, viability and knockdown experiments
- exposure
- Sulforaphane with or without selenium; peroxide challenge
- limitations
- Model-specific cytotoxicity; no conversion of culture concentrations into a safe or toxic oral dose.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Immortalized human hepatocytes and HepG2 comparison
- plain_language
- Exposure and cell type can change whether the effect is protective or harmful.
- primary_references
- [sulforaphane-p25683399] Synergy between sulforaphane and selenium in the up-regulation of thioredoxin reductase and protection against hydrogen peroxide-induced cell death in human hepatocytes. (2012). https://pubmed.ncbi.nlm.nih.gov/25683399/ DOI: 10.1016/j.foodchem.2012.01.026
- tissue_or_cell_type
- TXNRD1 response and toxicity
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 801–812
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Enzyme induction, viability and knockdown experiments · source_derived_draft · unverified_draft
### sulforaphane-hepatocyte-toxicity The study reported sulforaphane cytotoxicity IC50 values of 25.1 micromolar in hepatocytes and 56.4 micromolar in HepG2 cells alongside lower-exposure protective experiments. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Exposure and cell type can change whether the effect is protective or harmful. organism: Immortalized human hepatocytes and HepG2 comparison tissue_or_cell_type: TXNRD1 response and toxicity experimental_model: Enzyme induction, viability and knockdown experiments limitations: Model-specific cytotoxicity; no conversion of culture concentrations into a safe or toxic oral dose. exposure: Sulforaphane with or without selenium; peroxide challenge evidence_span: {"source_cache": "artifacts/sulforaphane-research/25683399.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bfaef8428737a984f51d1c91e9f6dddaf1d40a19c8ced9ddd7f6a222a65e450e", "start_char": 0, "end_char": 1707, "text_sha256": "bfaef8428737a984f51d1c91e9f6dddaf1d40a19c8ced9ddd7f6a222a65e450e"} [sulforaphane-p25683399] Synergy between sulforaphane and selenium in the up-regulation of thioredoxin reductase and protection against hydrogen peroxide-induced cell death in human hepatocytes. (2012). https://pubmed.ncbi.nlm.nih.gov/25683399/ DOI: 10.1016/j.foodchem.2012.01.026
Complete structured claim and evidenceSulforaphane decreased acetylated histone H3, H4 and tubulin markers in the cell comparisons despite reduced HDAC protein levels.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/25307283.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc736d6c2f2dc6c4026bdad0a5835d69ed094775076a2c1606f47020e6783331", "start_char": 0, "end_char": 1504, "text_sha256": "cc736d6c2f2dc6c4026bdad0a5835d69ed094775076a2c1606f47020e6783331"}
- experimental_model
- Matched cell-type and time-course comparison
- exposure
- Sulforaphane exposure; serum and time-course comparisons
- limitations
- Activity assays, protein abundance and substrate acetylation are distinct endpoints; mechanism of their divergence was not established. Erratum PMID 27271518 adds an omitted funding acknowledgment without revising these results.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HaCaT keratinocytes and HCT116 colon cancer cells
- plain_language
- Less enzyme protein did not produce the expected increase in acetylation.
- primary_references
- [sulforaphane-p25307283] The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses. (2015). https://pubmed.ncbi.nlm.nih.gov/25307283/ DOI: 10.1002/mc.22224
- tissue_or_cell_type
- HDAC activity, protein levels and target acetylation
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 606–617
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Matched cell-type and time-course comparison · source_derived_draft · unverified_draft
### sulforaphane-histone-acetylation-down Sulforaphane decreased acetylated histone H3, H4 and tubulin markers in the cell comparisons despite reduced HDAC protein levels. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Less enzyme protein did not produce the expected increase in acetylation. organism: Human HaCaT keratinocytes and HCT116 colon cancer cells tissue_or_cell_type: HDAC activity, protein levels and target acetylation experimental_model: Matched cell-type and time-course comparison limitations: Activity assays, protein abundance and substrate acetylation are distinct endpoints; mechanism of their divergence was not established. Erratum PMID 27271518 adds an omitted funding acknowledgment without revising these results. exposure: Sulforaphane exposure; serum and time-course comparisons evidence_span: {"source_cache": "artifacts/sulforaphane-research/25307283.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "cc736d6c2f2dc6c4026bdad0a5835d69ed094775076a2c1606f47020e6783331", "start_char": 0, "end_char": 1504, "text_sha256": "cc736d6c2f2dc6c4026bdad0a5835d69ed094775076a2c1606f47020e6783331"} [sulforaphane-p25307283] The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses. (2015). https://pubmed.ncbi.nlm.nih.gov/25307283/ DOI: 10.1002/mc.22224
Complete structured claim and evidenceSulforaphane exposure increased acetylated histones in HEK293 and HCT116 experiments, including increased acetylated histones at the HCT116 P21 promoter.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/15313918.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9478957b1513e25cb47f13d6a1aca0df542fc851d8eb4b9c6394010e90dbe83e", "start_char": 0, "end_char": 1861, "text_sha256": "9478957b1513e25cb47f13d6a1aca0df542fc851d8eb4b9c6394010e90dbe83e"}
- experimental_model
- Cell exposure, enzyme assays, metabolites and chromatin immunoprecipitation
- exposure
- Parent SFN, SFN-GSH, SFN-Cys and SFN-NAC; GST inhibition
- limitations
- High-level HDAC activity was measured without establishing universal isoform inhibition; cell effects are not cancer-treatment outcomes.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HEK293 and HCT116 cells
- plain_language
- The study measured a change to the chemical marks on DNA-packaging proteins.
- primary_references
- [sulforaphane-p15313918] A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. (2004). https://pubmed.ncbi.nlm.nih.gov/15313918/ DOI: 10.1158/0008-5472.can-04-1326
- tissue_or_cell_type
- Histone deacetylase activity and histone acetylation
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 593–604
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell exposure, enzyme assays, metabolites and chromatin immunoprecipitation · source_derived_draft · unverified_draft
### sulforaphane-histone-acetylation-up Sulforaphane exposure increased acetylated histones in HEK293 and HCT116 experiments, including increased acetylated histones at the HCT116 P21 promoter. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The study measured a change to the chemical marks on DNA-packaging proteins. organism: Human HEK293 and HCT116 cells tissue_or_cell_type: Histone deacetylase activity and histone acetylation experimental_model: Cell exposure, enzyme assays, metabolites and chromatin immunoprecipitation limitations: High-level HDAC activity was measured without establishing universal isoform inhibition; cell effects are not cancer-treatment outcomes. exposure: Parent SFN, SFN-GSH, SFN-Cys and SFN-NAC; GST inhibition evidence_span: {"source_cache": "artifacts/sulforaphane-research/15313918.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9478957b1513e25cb47f13d6a1aca0df542fc851d8eb4b9c6394010e90dbe83e", "start_char": 0, "end_char": 1861, "text_sha256": "9478957b1513e25cb47f13d6a1aca0df542fc851d8eb4b9c6394010e90dbe83e"} [sulforaphane-p15313918] A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. (2004). https://pubmed.ncbi.nlm.nih.gov/15313918/ DOI: 10.1158/0008-5472.can-04-1326
Complete structured claim and evidenceSulforaphane lowered HK2 expression associated with reduced entry of glucose into glycolysis.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/30595796.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274", "start_char": 0, "end_char": 2097, "text_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274"}
- experimental_model
- Replicative culture and metabolic/gene-expression measurements
- exposure
- Sulforaphane treatment during serial culture
- limitations
- Cell-culture senescence is not human longevity; expression is not necessarily flux.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MRC-5 and BJ fibroblasts
- plain_language
- The metabolic response included an early glucose-processing enzyme.
- primary_references
- [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
- tissue_or_cell_type
- Glucose handling, antioxidant response and senescence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 905–916
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Replicative culture and metabolic/gene-expression measurements · source_derived_draft · unverified_draft
### sulforaphane-hk2-expression Sulforaphane lowered HK2 expression associated with reduced entry of glucose into glycolysis. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The metabolic response included an early glucose-processing enzyme. organism: Human MRC-5 and BJ fibroblasts tissue_or_cell_type: Glucose handling, antioxidant response and senescence experimental_model: Replicative culture and metabolic/gene-expression measurements limitations: Cell-culture senescence is not human longevity; expression is not necessarily flux. exposure: Sulforaphane treatment during serial culture evidence_span: {"source_cache": "artifacts/sulforaphane-research/30595796.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274", "start_char": 0, "end_char": 2097, "text_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274"} [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
Complete structured claim and evidenceSulforaphane increased HMOX1 gene expression in early-passage nonsenescent MRC-5 fibroblasts.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/30595796.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13f25a5ca61ca9bdf80d4b24878682c90b414a5718a73b6a5b86ff20a9673279", "start_char": 14986, "end_char": 15205, "text_sha256": "c8a5b844826129e5cff61e4e19c0eb34f04a29a8feb8ced52a567eae1585d935"}
- experimental_model
- Replicative culture and metabolic/gene-expression measurements
- exposure
- Sulforaphane treatment during serial culture
- limitations
- Cell-culture senescence is not human longevity; expression is not necessarily flux.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MRC-5 and BJ fibroblasts
- plain_language
- The response includes this separately identified defense-system protein.
- primary_references
- [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
- tissue_or_cell_type
- Glucose handling, antioxidant response and senescence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 957–968
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Replicative culture and metabolic/gene-expression measurements · source_derived_draft · unverified_draft
### sulforaphane-hmox1-induction Sulforaphane increased HMOX1 gene expression in early-passage nonsenescent MRC-5 fibroblasts. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response includes this separately identified defense-system protein. organism: Human MRC-5 and BJ fibroblasts tissue_or_cell_type: Glucose handling, antioxidant response and senescence experimental_model: Replicative culture and metabolic/gene-expression measurements limitations: Cell-culture senescence is not human longevity; expression is not necessarily flux. exposure: Sulforaphane treatment during serial culture evidence_span: {"source_cache": "artifacts/sulforaphane-research/30595796.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "13f25a5ca61ca9bdf80d4b24878682c90b414a5718a73b6a5b86ff20a9673279", "start_char": 14986, "end_char": 15205, "text_sha256": "c8a5b844826129e5cff61e4e19c0eb34f04a29a8feb8ced52a567eae1585d935"} [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
Complete structured claim and evidenceHuman jejunal perfusion detected sulforaphane-GSH returned into the lumen after uptake.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/12756216.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af", "start_char": 0, "end_char": 1816, "text_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af"}
- experimental_model
- Human jejunal perfusion and parallel Caco-2 experiments
- exposure
- Dietary-concentration onion/broccoli extract perfusion
- limitations
- Human perfusion used a mixture; isolated Caco-2 comparisons help distinguish components. Local permeability is not systemic oral bioavailability.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human intestinal segment and human intestinal cell line
- plain_language
- Some absorbed material was processed and sent back into the gut.
- primary_references
- [sulforaphane-p12756216] Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. (2003). https://pubmed.ncbi.nlm.nih.gov/12756216/ DOI: 10.1124/dmd.31.6.805
- tissue_or_cell_type
- Absorption, luminal return and gene expression
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 398–409
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human jejunal perfusion and parallel Caco-2 experiments · source_derived_draft · unverified_draft
### sulforaphane-intestinal-return Human jejunal perfusion detected sulforaphane-GSH returned into the lumen after uptake. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Some absorbed material was processed and sent back into the gut. organism: Human intestinal segment and human intestinal cell line tissue_or_cell_type: Absorption, luminal return and gene expression experimental_model: Human jejunal perfusion and parallel Caco-2 experiments limitations: Human perfusion used a mixture; isolated Caco-2 comparisons help distinguish components. Local permeability is not systemic oral bioavailability. exposure: Dietary-concentration onion/broccoli extract perfusion evidence_span: {"source_cache": "artifacts/sulforaphane-research/12756216.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af", "start_char": 0, "end_char": 1816, "text_sha256": "98a56e8d1e84bffe3a4213eb3619d52869f85d999355d0e0f487d412149101af"} [sulforaphane-p12756216] Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. (2003). https://pubmed.ncbi.nlm.nih.gov/12756216/ DOI: 10.1124/dmd.31.6.805
Complete structured claim and evidenceRevised mass spectrometry detected sulforaphane modification of at least four KEAP1 cysteines, including readily modified C151.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/21391649.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d1ecbe68352504813e0a666dc7474fba7f0a3f3aeb5d0b2fea681d376df999ac", "start_char": 0, "end_char": 1511, "text_sha256": "d1ecbe68352504813e0a666dc7474fba7f0a3f3aeb5d0b2fea681d376df999ac"}
- experimental_model
- Mass spectrometry with revised sample preparation
- exposure
- Sulforaphane exposure; omission of iodoacetamide and shorter processing
- limitations
- Explains an assay-dependent detection problem; not an unresolved universal C151 disagreement or a human efficacy trial.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- KEAP1 protein cysteine mapping
- plain_language
- The molecule changes a sensor protein that controls the stress-response program.
- primary_references
- [sulforaphane-p21391649] Modification of keap1 cysteine residues by sulforaphane. (2011). https://pubmed.ncbi.nlm.nih.gov/21391649/ DOI: 10.1021/tx100389r
- tissue_or_cell_type
- Reversible electrophile-thiol adducts
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 424–435
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Mass spectrometry with revised sample preparation · source_derived_draft · unverified_draft
### sulforaphane-keap1-cysteines Revised mass spectrometry detected sulforaphane modification of at least four KEAP1 cysteines, including readily modified C151. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The molecule changes a sensor protein that controls the stress-response program. organism: KEAP1 protein cysteine mapping tissue_or_cell_type: Reversible electrophile-thiol adducts experimental_model: Mass spectrometry with revised sample preparation limitations: Explains an assay-dependent detection problem; not an unresolved universal C151 disagreement or a human efficacy trial. exposure: Sulforaphane exposure; omission of iodoacetamide and shorter processing evidence_span: {"source_cache": "artifacts/sulforaphane-research/21391649.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d1ecbe68352504813e0a666dc7474fba7f0a3f3aeb5d0b2fea681d376df999ac", "start_char": 0, "end_char": 1511, "text_sha256": "d1ecbe68352504813e0a666dc7474fba7f0a3f3aeb5d0b2fea681d376df999ac"} [sulforaphane-p21391649] Modification of keap1 cysteine residues by sulforaphane. (2011). https://pubmed.ncbi.nlm.nih.gov/21391649/ DOI: 10.1021/tx100389r
Complete structured claim and evidenceSulforaphane suppressed LPS-induced cytokine secretion in THP-1 cells and human PBMC experiments.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/25284333.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0a293f12863f5cfc2d57d74f4acee8c62700e2744a5900643bc23eca85c62be5", "start_char": 0, "end_char": 1494, "text_sha256": "0a293f12863f5cfc2d57d74f4acee8c62700e2744a5900643bc23eca85c62be5"}
- experimental_model
- Recombinant receptor mapping, human cell exposure and ex vivo challenge
- exposure
- Sulforaphane under non-reducing conditions; LPS challenge after ITC exposure
- limitations
- Covalent mapping does not establish the sole cause of cytokine effects; not a chronic-disease outcome trial.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human TLR4, THP-1 monocytes and donor PBMCs
- plain_language
- An inflammatory challenge produced a smaller response in these systems.
- primary_references
- [sulforaphane-p25284333] Suppression of LPS-induced transcription and cytokine secretion by the dietary isothiocyanate sulforaphane. (2014). https://pubmed.ncbi.nlm.nih.gov/25284333/ DOI: 10.1002/mnfr.201400550
- tissue_or_cell_type
- LPS recognition and cytokine secretion
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 684–695
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant receptor mapping, human cell exposure and ex vivo challenge · source_derived_draft · unverified_draft
### sulforaphane-lps-response Sulforaphane suppressed LPS-induced cytokine secretion in THP-1 cells and human PBMC experiments. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: An inflammatory challenge produced a smaller response in these systems. organism: Human TLR4, THP-1 monocytes and donor PBMCs tissue_or_cell_type: LPS recognition and cytokine secretion experimental_model: Recombinant receptor mapping, human cell exposure and ex vivo challenge limitations: Covalent mapping does not establish the sole cause of cytokine effects; not a chronic-disease outcome trial. exposure: Sulforaphane under non-reducing conditions; LPS challenge after ITC exposure evidence_span: {"source_cache": "artifacts/sulforaphane-research/25284333.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0a293f12863f5cfc2d57d74f4acee8c62700e2744a5900643bc23eca85c62be5", "start_char": 0, "end_char": 1494, "text_sha256": "0a293f12863f5cfc2d57d74f4acee8c62700e2744a5900643bc23eca85c62be5"} [sulforaphane-p25284333] Suppression of LPS-induced transcription and cytokine secretion by the dietary isothiocyanate sulforaphane. (2014). https://pubmed.ncbi.nlm.nih.gov/25284333/ DOI: 10.1002/mnfr.201400550
Complete structured claim and evidenceSulforaphane induced Nrf2-dependent MRP1 expression in CRL-1790 cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/27636860.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "38b05ba233878d75f74373f3093e4d51bbbbb417b59f06dec578f7c293e12793", "start_char": 0, "end_char": 1177, "text_sha256": "38b05ba233878d75f74373f3093e4d51bbbbb417b59f06dec578f7c293e12793"}
- experimental_model
- Gene and enzyme-response comparison
- exposure
- Sulforaphane exposure across three cell contexts
- limitations
- Cancer and untransformed cells regulated the pathway differently; no claim that all Nrf2 activation is desirable in established tumors.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human CRL-1790 untransformed colon cells, HT-29 and Caco-2 cancer cells
- plain_language
- The response can increase an export transporter as well as enzymes.
- primary_references
- [sulforaphane-p27636860] Sulforaphane Regulates NFE2L2/Nrf2-Dependent Xenobiotic Metabolism Phase II and Phase III Enzymes Differently in Human Colorectal Cancer and Untransformed Epithelial Colon Cells. (2016). https://pubmed.ncbi.nlm.nih.gov/27636860/ DOI: 10.1080/01635581.2016.1224369
- tissue_or_cell_type
- Nrf2 targets and cell defense
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 554–565
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Gene and enzyme-response comparison · source_derived_draft · unverified_draft
### sulforaphane-mrp1-induction Sulforaphane induced Nrf2-dependent MRP1 expression in CRL-1790 cells. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response can increase an export transporter as well as enzymes. organism: Human CRL-1790 untransformed colon cells, HT-29 and Caco-2 cancer cells tissue_or_cell_type: Nrf2 targets and cell defense experimental_model: Gene and enzyme-response comparison limitations: Cancer and untransformed cells regulated the pathway differently; no claim that all Nrf2 activation is desirable in established tumors. exposure: Sulforaphane exposure across three cell contexts evidence_span: {"source_cache": "artifacts/sulforaphane-research/27636860.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "38b05ba233878d75f74373f3093e4d51bbbbb417b59f06dec578f7c293e12793", "start_char": 0, "end_char": 1177, "text_sha256": "38b05ba233878d75f74373f3093e4d51bbbbb417b59f06dec578f7c293e12793"} [sulforaphane-p27636860] Sulforaphane Regulates NFE2L2/Nrf2-Dependent Xenobiotic Metabolism Phase II and Phase III Enzymes Differently in Human Colorectal Cancer and Untransformed Epithelial Colon Cells. (2016). https://pubmed.ncbi.nlm.nih.gov/27636860/ DOI: 10.1080/01635581.2016.1224369
Complete structured claim and evidenceSulforaphane inhibited mTOR signaling in U2OS cells both with and without NRF2.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/31409554.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b", "start_char": 0, "end_char": 1778, "text_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b"}
- experimental_model
- Human cell experiments with CRISPR NRF2 deletion
- exposure
- Concentration- and time-dependent sulforaphane treatment
- limitations
- Preclinical cancer-cell signaling; AKT phosphorylation did not reliably represent catalytic output. Not a human longevity or autophagy trial.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human U2OS osteosarcoma cells and NRF2-knockout counterpart
- plain_language
- Some effects remain when the familiar NRF2 pathway is absent.
- primary_references
- [sulforaphane-p31409554] The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. (2021). https://pubmed.ncbi.nlm.nih.gov/31409554/ DOI: 10.1016/j.phymed.2019.153062
- tissue_or_cell_type
- HDAC6, AKT and mTOR signaling
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 632–643
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human cell experiments with CRISPR NRF2 deletion · source_derived_draft · unverified_draft
### sulforaphane-mtor-independent Sulforaphane inhibited mTOR signaling in U2OS cells both with and without NRF2. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Some effects remain when the familiar NRF2 pathway is absent. organism: Human U2OS osteosarcoma cells and NRF2-knockout counterpart tissue_or_cell_type: HDAC6, AKT and mTOR signaling experimental_model: Human cell experiments with CRISPR NRF2 deletion limitations: Preclinical cancer-cell signaling; AKT phosphorylation did not reliably represent catalytic output. Not a human longevity or autophagy trial. exposure: Concentration- and time-dependent sulforaphane treatment evidence_span: {"source_cache": "artifacts/sulforaphane-research/31409554.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b", "start_char": 0, "end_char": 1778, "text_sha256": "5486f97c1271a771620cdf2e6245a54ff63f3f56b3eb884f201fda9882ec947b"} [sulforaphane-p31409554] The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. (2021). https://pubmed.ncbi.nlm.nih.gov/31409554/ DOI: 10.1016/j.phymed.2019.153062
Complete structured claim and evidenceSulforaphane induced Nrf2-dependent NQO1 expression in untransformed human CRL-1790 colon cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/27636860.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "38b05ba233878d75f74373f3093e4d51bbbbb417b59f06dec578f7c293e12793", "start_char": 0, "end_char": 1177, "text_sha256": "38b05ba233878d75f74373f3093e4d51bbbbb417b59f06dec578f7c293e12793"}
- experimental_model
- Gene and enzyme-response comparison
- exposure
- Sulforaphane exposure across three cell contexts
- limitations
- Cancer and untransformed cells regulated the pathway differently; no claim that all Nrf2 activation is desirable in established tumors.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human CRL-1790 untransformed colon cells, HT-29 and Caco-2 cancer cells
- plain_language
- One induced enzyme handles quinone chemistry.
- primary_references
- [sulforaphane-p27636860] Sulforaphane Regulates NFE2L2/Nrf2-Dependent Xenobiotic Metabolism Phase II and Phase III Enzymes Differently in Human Colorectal Cancer and Untransformed Epithelial Colon Cells. (2016). https://pubmed.ncbi.nlm.nih.gov/27636860/ DOI: 10.1080/01635581.2016.1224369
- tissue_or_cell_type
- Nrf2 targets and cell defense
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 541–552
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Gene and enzyme-response comparison · source_derived_draft · unverified_draft
### sulforaphane-nqo1-induction Sulforaphane induced Nrf2-dependent NQO1 expression in untransformed human CRL-1790 colon cells. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: One induced enzyme handles quinone chemistry. organism: Human CRL-1790 untransformed colon cells, HT-29 and Caco-2 cancer cells tissue_or_cell_type: Nrf2 targets and cell defense experimental_model: Gene and enzyme-response comparison limitations: Cancer and untransformed cells regulated the pathway differently; no claim that all Nrf2 activation is desirable in established tumors. exposure: Sulforaphane exposure across three cell contexts evidence_span: {"source_cache": "artifacts/sulforaphane-research/27636860.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "38b05ba233878d75f74373f3093e4d51bbbbb417b59f06dec578f7c293e12793", "start_char": 0, "end_char": 1177, "text_sha256": "38b05ba233878d75f74373f3093e4d51bbbbb417b59f06dec578f7c293e12793"} [sulforaphane-p27636860] Sulforaphane Regulates NFE2L2/Nrf2-Dependent Xenobiotic Metabolism Phase II and Phase III Enzymes Differently in Human Colorectal Cancer and Untransformed Epithelial Colon Cells. (2016). https://pubmed.ncbi.nlm.nih.gov/27636860/ DOI: 10.1080/01635581.2016.1224369
Complete structured claim and evidenceSulforaphane increased nuclear localization of stabilized Nrf2 and Nrf2-dependent gene activation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/14585973.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bc2e1304879d9bd3d1b4946981f93a78d3f604c580ea252af17f645e237cadd0", "start_char": 0, "end_char": 1647, "text_sha256": "bc2e1304879d9bd3d1b4946981f93a78d3f604c580ea252af17f645e237cadd0"}
- experimental_model
- KEAP1 mutagenesis and Nrf2 stability/localization assays
- exposure
- Sulforaphane or oxidative stress; C151/C273/C288 variants
- limitations
- Individual cysteines have different roles; activating Nrf2 does not establish prevention or treatment of cancer in humans.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human KEAP1 constructs in cellular experiments
- plain_language
- The regulator accumulates where it can influence gene expression.
- primary_references
- [sulforaphane-p14585973] Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. (2003). https://pubmed.ncbi.nlm.nih.gov/14585973/ DOI: 10.1128/mcb.23.22.8137-8151.2003
- tissue_or_cell_type
- Ubiquitination, protein turnover and nuclear localization
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 528–539
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · KEAP1 mutagenesis and Nrf2 stability/localization assays · source_derived_draft · unverified_draft
### sulforaphane-nrf2-nuclear Sulforaphane increased nuclear localization of stabilized Nrf2 and Nrf2-dependent gene activation. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The regulator accumulates where it can influence gene expression. organism: Human KEAP1 constructs in cellular experiments tissue_or_cell_type: Ubiquitination, protein turnover and nuclear localization experimental_model: KEAP1 mutagenesis and Nrf2 stability/localization assays limitations: Individual cysteines have different roles; activating Nrf2 does not establish prevention or treatment of cancer in humans. exposure: Sulforaphane or oxidative stress; C151/C273/C288 variants evidence_span: {"source_cache": "artifacts/sulforaphane-research/14585973.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bc2e1304879d9bd3d1b4946981f93a78d3f604c580ea252af17f645e237cadd0", "start_char": 0, "end_char": 1647, "text_sha256": "bc2e1304879d9bd3d1b4946981f93a78d3f604c580ea252af17f645e237cadd0"} [sulforaphane-p14585973] Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. (2003). https://pubmed.ncbi.nlm.nih.gov/14585973/ DOI: 10.1128/mcb.23.22.8137-8151.2003
Complete structured claim and evidenceSulforaphane enabled Nrf2 to escape KEAP1-dependent degradation and increased its stability.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/14585973.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bc2e1304879d9bd3d1b4946981f93a78d3f604c580ea252af17f645e237cadd0", "start_char": 0, "end_char": 1647, "text_sha256": "bc2e1304879d9bd3d1b4946981f93a78d3f604c580ea252af17f645e237cadd0"}
- experimental_model
- KEAP1 mutagenesis and Nrf2 stability/localization assays
- exposure
- Sulforaphane or oxidative stress; C151/C273/C288 variants
- limitations
- Individual cysteines have different roles; activating Nrf2 does not establish prevention or treatment of cancer in humans.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human KEAP1 constructs in cellular experiments
- plain_language
- The cell keeps more of the regulator available.
- primary_references
- [sulforaphane-p14585973] Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. (2003). https://pubmed.ncbi.nlm.nih.gov/14585973/ DOI: 10.1128/mcb.23.22.8137-8151.2003
- tissue_or_cell_type
- Ubiquitination, protein turnover and nuclear localization
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 515–526
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · KEAP1 mutagenesis and Nrf2 stability/localization assays · source_derived_draft · unverified_draft
### sulforaphane-nrf2-stability Sulforaphane enabled Nrf2 to escape KEAP1-dependent degradation and increased its stability. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The cell keeps more of the regulator available. organism: Human KEAP1 constructs in cellular experiments tissue_or_cell_type: Ubiquitination, protein turnover and nuclear localization experimental_model: KEAP1 mutagenesis and Nrf2 stability/localization assays limitations: Individual cysteines have different roles; activating Nrf2 does not establish prevention or treatment of cancer in humans. exposure: Sulforaphane or oxidative stress; C151/C273/C288 variants evidence_span: {"source_cache": "artifacts/sulforaphane-research/14585973.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "bc2e1304879d9bd3d1b4946981f93a78d3f604c580ea252af17f645e237cadd0", "start_char": 0, "end_char": 1647, "text_sha256": "bc2e1304879d9bd3d1b4946981f93a78d3f604c580ea252af17f645e237cadd0"} [sulforaphane-p14585973] Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. (2003). https://pubmed.ncbi.nlm.nih.gov/14585973/ DOI: 10.1128/mcb.23.22.8137-8151.2003
Complete structured claim and evidenceSulforaphane delayed replicative senescence of cultured MRC-5 and BJ fibroblasts.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/30595796.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274", "start_char": 0, "end_char": 2097, "text_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274"}
- experimental_model
- Replicative culture and metabolic/gene-expression measurements
- exposure
- Sulforaphane treatment during serial culture
- limitations
- Cell-culture senescence is not human longevity; expression is not necessarily flux.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MRC-5 and BJ fibroblasts
- plain_language
- The cells reached the study-defined senescent state later; human lifespan was not tested.
- primary_references
- [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
- tissue_or_cell_type
- Glucose handling, antioxidant response and senescence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 918–929
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Replicative culture and metabolic/gene-expression measurements · source_derived_draft · unverified_draft
### sulforaphane-senescence-delay Sulforaphane delayed replicative senescence of cultured MRC-5 and BJ fibroblasts. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The cells reached the study-defined senescent state later; human lifespan was not tested. organism: Human MRC-5 and BJ fibroblasts tissue_or_cell_type: Glucose handling, antioxidant response and senescence experimental_model: Replicative culture and metabolic/gene-expression measurements limitations: Cell-culture senescence is not human longevity; expression is not necessarily flux. exposure: Sulforaphane treatment during serial culture evidence_span: {"source_cache": "artifacts/sulforaphane-research/30595796.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274", "start_char": 0, "end_char": 2097, "text_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274"} [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
Complete structured claim and evidenceSulforaphane inhibited KEAP1-dependent ubiquitination of Nrf2.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/15572695.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765", "start_char": 0, "end_char": 1484, "text_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765"}
- experimental_model
- Cell transfection, coimmunoprecipitation and ubiquitination assays
- exposure
- Sulforaphane or quinone stress; C151S KEAP1 comparison
- limitations
- The measured interaction is ubiquitin-ligase regulation; do not describe it as obligatory physical release of all bound Nrf2.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human protein constructs in mammalian cell systems
- plain_language
- Less disposal allows the regulator to persist.
- primary_references
- [sulforaphane-p15572695] Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. (2004). https://pubmed.ncbi.nlm.nih.gov/15572695/ DOI: 10.1128/mcb.24.24.10941-10953.2004
- tissue_or_cell_type
- KEAP1-CUL3-RBX1 control of Nrf2
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 476–487
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell transfection, coimmunoprecipitation and ubiquitination assays · source_derived_draft · unverified_draft
### sulforaphane-sfn-ubiquitination Sulforaphane inhibited KEAP1-dependent ubiquitination of Nrf2. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Less disposal allows the regulator to persist. organism: Human protein constructs in mammalian cell systems tissue_or_cell_type: KEAP1-CUL3-RBX1 control of Nrf2 experimental_model: Cell transfection, coimmunoprecipitation and ubiquitination assays limitations: The measured interaction is ubiquitin-ligase regulation; do not describe it as obligatory physical release of all bound Nrf2. exposure: Sulforaphane or quinone stress; C151S KEAP1 comparison evidence_span: {"source_cache": "artifacts/sulforaphane-research/15572695.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765", "start_char": 0, "end_char": 1484, "text_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765"} [sulforaphane-p15572695] Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. (2004). https://pubmed.ncbi.nlm.nih.gov/15572695/ DOI: 10.1128/mcb.24.24.10941-10953.2004
Complete structured claim and evidenceReceptor mapping found sulforaphane adducts at TLR4 C246 and C609 under non-reducing conditions.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/25284333.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0a293f12863f5cfc2d57d74f4acee8c62700e2744a5900643bc23eca85c62be5", "start_char": 0, "end_char": 1494, "text_sha256": "0a293f12863f5cfc2d57d74f4acee8c62700e2744a5900643bc23eca85c62be5"}
- experimental_model
- Recombinant receptor mapping, human cell exposure and ex vivo challenge
- exposure
- Sulforaphane under non-reducing conditions; LPS challenge after ITC exposure
- limitations
- Covalent mapping does not establish the sole cause of cytokine effects; not a chronic-disease outcome trial.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human TLR4, THP-1 monocytes and donor PBMCs
- plain_language
- The compound can interact with an inflammatory sensor as well as KEAP1.
- primary_references
- [sulforaphane-p25284333] Suppression of LPS-induced transcription and cytokine secretion by the dietary isothiocyanate sulforaphane. (2014). https://pubmed.ncbi.nlm.nih.gov/25284333/ DOI: 10.1002/mnfr.201400550
- tissue_or_cell_type
- LPS recognition and cytokine secretion
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 671–682
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant receptor mapping, human cell exposure and ex vivo challenge · source_derived_draft · unverified_draft
### sulforaphane-tlr4-adduct Receptor mapping found sulforaphane adducts at TLR4 C246 and C609 under non-reducing conditions. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The compound can interact with an inflammatory sensor as well as KEAP1. organism: Human TLR4, THP-1 monocytes and donor PBMCs tissue_or_cell_type: LPS recognition and cytokine secretion experimental_model: Recombinant receptor mapping, human cell exposure and ex vivo challenge limitations: Covalent mapping does not establish the sole cause of cytokine effects; not a chronic-disease outcome trial. exposure: Sulforaphane under non-reducing conditions; LPS challenge after ITC exposure evidence_span: {"source_cache": "artifacts/sulforaphane-research/25284333.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0a293f12863f5cfc2d57d74f4acee8c62700e2744a5900643bc23eca85c62be5", "start_char": 0, "end_char": 1494, "text_sha256": "0a293f12863f5cfc2d57d74f4acee8c62700e2744a5900643bc23eca85c62be5"} [sulforaphane-p25284333] Suppression of LPS-induced transcription and cytokine secretion by the dietary isothiocyanate sulforaphane. (2014). https://pubmed.ncbi.nlm.nih.gov/25284333/ DOI: 10.1002/mnfr.201400550
Complete structured claim and evidenceSulforaphane increased TXNIP expression alongside reduced glucose entry in the studied fibroblasts.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/30595796.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274", "start_char": 0, "end_char": 2097, "text_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274"}
- experimental_model
- Replicative culture and metabolic/gene-expression measurements
- exposure
- Sulforaphane treatment during serial culture
- limitations
- Cell-culture senescence is not human longevity; expression is not necessarily flux.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MRC-5 and BJ fibroblasts
- plain_language
- A regulatory protein can change how much fuel enters the cell.
- primary_references
- [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
- tissue_or_cell_type
- Glucose handling, antioxidant response and senescence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 892–903
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Replicative culture and metabolic/gene-expression measurements · source_derived_draft · unverified_draft
### sulforaphane-txnip-expression Sulforaphane increased TXNIP expression alongside reduced glucose entry in the studied fibroblasts. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: A regulatory protein can change how much fuel enters the cell. organism: Human MRC-5 and BJ fibroblasts tissue_or_cell_type: Glucose handling, antioxidant response and senescence experimental_model: Replicative culture and metabolic/gene-expression measurements limitations: Cell-culture senescence is not human longevity; expression is not necessarily flux. exposure: Sulforaphane treatment during serial culture evidence_span: {"source_cache": "artifacts/sulforaphane-research/30595796.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274", "start_char": 0, "end_char": 2097, "text_sha256": "aa7d5e0ef15224906eb42eb49309439c966c30310740dbdea9553b76b2f91274"} [sulforaphane-p30595796] Sulforaphane Delays Fibroblast Senescence by Curbing Cellular Glucose Uptake, Increased Glycolysis, and Oxidative Damage. (2018). https://pubmed.ncbi.nlm.nih.gov/30595796/ DOI: 10.1155/2018/5642148
Complete structured claim and evidenceSulforaphane increased TXNRD1 mRNA up to fourfold; TXNRD2 mRNA did not show this induction.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"}
- experimental_model
- Transcription/translation and inhibitor experiments
- exposure
- Sulforaphane, sodium selenite, combined treatment and pathway inhibitors
- limitations
- Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HepG2 hepatoma cells
- plain_language
- One cytosolic enzyme gene responded while the mitochondrial counterpart did not.
- primary_references
- [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
- tissue_or_cell_type
- Thioredoxin reductase regulation
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 697–708
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transcription/translation and inhibitor experiments · source_derived_draft · unverified_draft
### sulforaphane-txnrd1-transcription Sulforaphane increased TXNRD1 mRNA up to fourfold; TXNRD2 mRNA did not show this induction. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: One cytosolic enzyme gene responded while the mitochondrial counterpart did not. organism: Human HepG2 hepatoma cells tissue_or_cell_type: Thioredoxin reductase regulation experimental_model: Transcription/translation and inhibitor experiments limitations: Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable. exposure: Sulforaphane, sodium selenite, combined treatment and pathway inhibitors evidence_span: {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"} [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
Complete structured claim and evidenceSulforaphane caused time-dependent urease inactivation with spectroscopic evidence of cysteine-thiol adduct formation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/23583386.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4542d001efffa337d1aae4de7767a914ed8cd951bc5e56ded5183046abe10577", "start_char": 0, "end_char": 1843, "text_sha256": "4542d001efffa337d1aae4de7767a914ed8cd951bc5e56ded5183046abe10577"}
- experimental_model
- Purified urease assays and bacterial comparisons
- exposure
- Sulforaphane and related isothiocyanates
- limitations
- Urease inactivation was not obligatory for bacterial killing; do not portray one target as the entire antibacterial mechanism.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- H. pylori and jack-bean urease experiments
- plain_language
- The compound can chemically inhibit a bacterial enzyme.
- primary_references
- [sulforaphane-p23583386] Urease from Helicobacter pylori is inactivated by sulforaphane and other isothiocyanates. (2013). https://pubmed.ncbi.nlm.nih.gov/23583386/ DOI: 10.1016/j.bbrc.2013.03.126
- tissue_or_cell_type
- Urease modification and bacterial killing
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1282–1293
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified urease assays and bacterial comparisons · source_derived_draft · unverified_draft
### sulforaphane-urease-inactivation Sulforaphane caused time-dependent urease inactivation with spectroscopic evidence of cysteine-thiol adduct formation. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The compound can chemically inhibit a bacterial enzyme. organism: H. pylori and jack-bean urease experiments tissue_or_cell_type: Urease modification and bacterial killing experimental_model: Purified urease assays and bacterial comparisons limitations: Urease inactivation was not obligatory for bacterial killing; do not portray one target as the entire antibacterial mechanism. exposure: Sulforaphane and related isothiocyanates evidence_span: {"source_cache": "artifacts/sulforaphane-research/23583386.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4542d001efffa337d1aae4de7767a914ed8cd951bc5e56ded5183046abe10577", "start_char": 0, "end_char": 1843, "text_sha256": "4542d001efffa337d1aae4de7767a914ed8cd951bc5e56ded5183046abe10577"} [sulforaphane-p23583386] Urease from Helicobacter pylori is inactivated by sulforaphane and other isothiocyanates. (2013). https://pubmed.ncbi.nlm.nih.gov/23583386/ DOI: 10.1016/j.bbrc.2013.03.126
Complete structured claim and evidenceSulforaphane killed both urease-positive and urease-negative H. pylori strains.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/23583386.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4542d001efffa337d1aae4de7767a914ed8cd951bc5e56ded5183046abe10577", "start_char": 0, "end_char": 1843, "text_sha256": "4542d001efffa337d1aae4de7767a914ed8cd951bc5e56ded5183046abe10577"}
- experimental_model
- Purified urease assays and bacterial comparisons
- exposure
- Sulforaphane and related isothiocyanates
- limitations
- Urease inactivation was not obligatory for bacterial killing; do not portray one target as the entire antibacterial mechanism.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- H. pylori and jack-bean urease experiments
- plain_language
- The antibacterial effect cannot be explained solely by blocking urease.
- primary_references
- [sulforaphane-p23583386] Urease from Helicobacter pylori is inactivated by sulforaphane and other isothiocyanates. (2013). https://pubmed.ncbi.nlm.nih.gov/23583386/ DOI: 10.1016/j.bbrc.2013.03.126
- tissue_or_cell_type
- Urease modification and bacterial killing
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1295–1306
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified urease assays and bacterial comparisons · source_derived_draft · unverified_draft
### sulforaphane-urease-independent-killing Sulforaphane killed both urease-positive and urease-negative H. pylori strains. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The antibacterial effect cannot be explained solely by blocking urease. organism: H. pylori and jack-bean urease experiments tissue_or_cell_type: Urease modification and bacterial killing experimental_model: Purified urease assays and bacterial comparisons limitations: Urease inactivation was not obligatory for bacterial killing; do not portray one target as the entire antibacterial mechanism. exposure: Sulforaphane and related isothiocyanates evidence_span: {"source_cache": "artifacts/sulforaphane-research/23583386.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "4542d001efffa337d1aae4de7767a914ed8cd951bc5e56ded5183046abe10577", "start_char": 0, "end_char": 1843, "text_sha256": "4542d001efffa337d1aae4de7767a914ed8cd951bc5e56ded5183046abe10577"} [sulforaphane-p23583386] Urease from Helicobacter pylori is inactivated by sulforaphane and other isothiocyanates. (2013). https://pubmed.ncbi.nlm.nih.gov/23583386/ DOI: 10.1016/j.bbrc.2013.03.126
Complete structured claim and evidenceSulforaphane-cysteine was separately quantified in human urine after broccoli sprout exposure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"}
- experimental_model
- Isotope-dilution LC-MS/MS assay validation in intervention urines
- exposure
- Broccoli sprout intervention specimens with equivalent administered preparation
- limitations
- Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 98 urine specimens
- plain_language
- This metabolite has its own identity and can be measured separately from the parent.
- primary_references
- [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
- tissue_or_cell_type
- Urinary mercapturic-acid pathway species
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 359–370
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isotope-dilution LC-MS/MS assay validation in intervention urines · source_derived_draft · unverified_draft
### sulforaphane-urine-cys Sulforaphane-cysteine was separately quantified in human urine after broccoli sprout exposure. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: This metabolite has its own identity and can be measured separately from the parent. organism: Human, 98 urine specimens tissue_or_cell_type: Urinary mercapturic-acid pathway species experimental_model: Isotope-dilution LC-MS/MS assay validation in intervention urines limitations: Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme. exposure: Broccoli sprout intervention specimens with equivalent administered preparation evidence_span: {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"} [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
Complete structured claim and evidenceSulforaphane-cysteinylglycine was separately quantified in human urine after broccoli sprout exposure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"}
- experimental_model
- Isotope-dilution LC-MS/MS assay validation in intervention urines
- exposure
- Broccoli sprout intervention specimens with equivalent administered preparation
- limitations
- Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 98 urine specimens
- plain_language
- This metabolite has its own identity and can be measured separately from the parent.
- primary_references
- [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
- tissue_or_cell_type
- Urinary mercapturic-acid pathway species
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 346–357
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isotope-dilution LC-MS/MS assay validation in intervention urines · source_derived_draft · unverified_draft
### sulforaphane-urine-cysgly Sulforaphane-cysteinylglycine was separately quantified in human urine after broccoli sprout exposure. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: This metabolite has its own identity and can be measured separately from the parent. organism: Human, 98 urine specimens tissue_or_cell_type: Urinary mercapturic-acid pathway species experimental_model: Isotope-dilution LC-MS/MS assay validation in intervention urines limitations: Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme. exposure: Broccoli sprout intervention specimens with equivalent administered preparation evidence_span: {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"} [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
Complete structured claim and evidenceSulforaphane-glutathione was separately quantified in human urine after broccoli sprout exposure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"}
- experimental_model
- Isotope-dilution LC-MS/MS assay validation in intervention urines
- exposure
- Broccoli sprout intervention specimens with equivalent administered preparation
- limitations
- Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 98 urine specimens
- plain_language
- This metabolite has its own identity and can be measured separately from the parent.
- primary_references
- [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
- tissue_or_cell_type
- Urinary mercapturic-acid pathway species
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 333–344
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isotope-dilution LC-MS/MS assay validation in intervention urines · source_derived_draft · unverified_draft
### sulforaphane-urine-gsh Sulforaphane-glutathione was separately quantified in human urine after broccoli sprout exposure. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: This metabolite has its own identity and can be measured separately from the parent. organism: Human, 98 urine specimens tissue_or_cell_type: Urinary mercapturic-acid pathway species experimental_model: Isotope-dilution LC-MS/MS assay validation in intervention urines limitations: Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme. exposure: Broccoli sprout intervention specimens with equivalent administered preparation evidence_span: {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"} [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
Complete structured claim and evidenceSulforaphane-N-acetylcysteine was separately quantified in human urine after broccoli sprout exposure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"}
- experimental_model
- Isotope-dilution LC-MS/MS assay validation in intervention urines
- exposure
- Broccoli sprout intervention specimens with equivalent administered preparation
- limitations
- Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 98 urine specimens
- plain_language
- This metabolite has its own identity and can be measured separately from the parent.
- primary_references
- [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
- tissue_or_cell_type
- Urinary mercapturic-acid pathway species
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 372–383
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isotope-dilution LC-MS/MS assay validation in intervention urines · source_derived_draft · unverified_draft
### sulforaphane-urine-nac Sulforaphane-N-acetylcysteine was separately quantified in human urine after broccoli sprout exposure. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: This metabolite has its own identity and can be measured separately from the parent. organism: Human, 98 urine specimens tissue_or_cell_type: Urinary mercapturic-acid pathway species experimental_model: Isotope-dilution LC-MS/MS assay validation in intervention urines limitations: Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme. exposure: Broccoli sprout intervention specimens with equivalent administered preparation evidence_span: {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"} [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
Complete structured claim and evidenceSulforaphane-affinity beads captured APT2 from Huh-7 or transfected HEK293 lysates; C56S mutation attenuated binding in the reported assays.
Experimental context and source evidence
- evidence_cache
- artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a
- experimental_model
- Human Huh-7 and HEK293 cell lysates; endogenous or FLAG-tagged human APT2
- exposure
- Bead pulldown; free-sulforaphane competition at 100 micromolar for 30 minutes at 4 C. C56S and C2S constructs compared.
- limitations
- These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. Mutagenesis supports C56-dependent engagement; no binding affinity or substrate-specific catalytic inhibition constant was established.
- organism
- Human experimental cells; construct species unresolved where stated for discussion-only nulls
- primary_locator
- Figures 1 and 3, Results 3.1 and 3.3
- primary_references
- https://doi.org/10.1016/j.bbrc.2024.150244
- source_access
- Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis.
APT2: sulforaphane engagement, GPX4 stability and ZDHHC6 turnover · lines 8–16
Targeted primary-literature curation from recursive ZDHHC6 exploration, 2026-09-20. · supports · Human Huh-7 and HEK293 cell lysates; endogenous or FLAG-tagged human APT2 · source_derived_draft · unverified_draft
Sulforaphane-affinity beads captured APT2 from Huh-7 or transfected HEK293 lysates; C56S mutation attenuated binding in the reported assays. primary_references: https://doi.org/10.1016/j.bbrc.2024.150244 primary_locator: Figures 1 and 3, Results 3.1 and 3.3 source_access: Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis. evidence_cache: artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a experimental_model: Human Huh-7 and HEK293 cell lysates; endogenous or FLAG-tagged human APT2 organism: Human experimental cells; construct species unresolved where stated for discussion-only nulls exposure: Bead pulldown; free-sulforaphane competition at 100 micromolar for 30 minutes at 4 C. C56S and C2S constructs compared. limitations: These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. Mutagenesis supports C56-dependent engagement; no binding affinity or substrate-specific catalytic inhibition constant was established.
Complete structured claim and evidenceSulforaphane reduced the membrane-to-cytosol ratio of FLAG-tagged APT2 in HEK293 fractionation experiments.
Experimental context and source evidence
- evidence_cache
- artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a
- experimental_model
- Human HEK293 expressing FLAG-tagged human APT2
- exposure
- 100 micromolar sulforaphane for 3 hours; membrane and cytosol fractions with pan-cadherin and alpha-tubulin markers; three separate experiments.
- limitations
- These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. The authors describe plasma-membrane localization, but fractionation is not an ER-specific or organelle-resolved measurement.
- organism
- Human experimental cells; construct species unresolved where stated for discussion-only nulls
- primary_locator
- Figure 4A; Results 3.4 and Methods 2.9
- primary_references
- https://doi.org/10.1016/j.bbrc.2024.150244
- source_access
- Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis.
APT2: sulforaphane engagement, GPX4 stability and ZDHHC6 turnover · lines 30–38
Targeted primary-literature curation from recursive ZDHHC6 exploration, 2026-09-20. · supports · Human HEK293 expressing FLAG-tagged human APT2 · source_derived_draft · unverified_draft
Sulforaphane reduced the membrane-to-cytosol ratio of FLAG-tagged APT2 in HEK293 fractionation experiments. primary_references: https://doi.org/10.1016/j.bbrc.2024.150244 primary_locator: Figure 4A; Results 3.4 and Methods 2.9 source_access: Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis. evidence_cache: artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a experimental_model: Human HEK293 expressing FLAG-tagged human APT2 organism: Human experimental cells; construct species unresolved where stated for discussion-only nulls exposure: 100 micromolar sulforaphane for 3 hours; membrane and cytosol fractions with pan-cadherin and alpha-tubulin markers; three separate experiments. limitations: These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. The authors describe plasma-membrane localization, but fractionation is not an ER-specific or organelle-resolved measurement.
Complete structured claim and evidenceSulforaphane reduced Alk14 labeling of immunoprecipitated APT2 in transfected HEK293 cells.
Experimental context and source evidence
- evidence_cache
- artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a
- experimental_model
- Human HEK293 expressing FLAG-tagged human APT2
- exposure
- 100 micromolar sulforaphane for 3 hours followed by 50 micromolar Alk14 for 5 hours; hydroxylamine control; three separate experiments.
- limitations
- These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. The authors could not distinguish reduced palmitoylation from enhanced depalmitoylation. This assay does not measure GPX4 or ZDHHC6.
- organism
- Human experimental cells; construct species unresolved where stated for discussion-only nulls
- primary_locator
- Figure 4B; Methods 2.8
- primary_references
- https://doi.org/10.1016/j.bbrc.2024.150244
- source_access
- Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis.
APT2: sulforaphane engagement, GPX4 stability and ZDHHC6 turnover · lines 19–27
Targeted primary-literature curation from recursive ZDHHC6 exploration, 2026-09-20. · supports · Human HEK293 expressing FLAG-tagged human APT2 · source_derived_draft · unverified_draft
Sulforaphane reduced Alk14 labeling of immunoprecipitated APT2 in transfected HEK293 cells. primary_references: https://doi.org/10.1016/j.bbrc.2024.150244 primary_locator: Figure 4B; Methods 2.8 source_access: Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis. evidence_cache: artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a experimental_model: Human HEK293 expressing FLAG-tagged human APT2 organism: Human experimental cells; construct species unresolved where stated for discussion-only nulls exposure: 100 micromolar sulforaphane for 3 hours followed by 50 micromolar Alk14 for 5 hours; hydroxylamine control; three separate experiments. limitations: These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. The authors could not distinguish reduced palmitoylation from enhanced depalmitoylation. This assay does not measure GPX4 or ZDHHC6.
Complete structured claim and evidenceThe sulforaphane study reports no significant change in GAP-43 palmitoylation in the presence of sulforaphane.
Experimental context and source evidence
- evidence_cache
- artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a
- experimental_model
- Cell model and construct species not specified for this discussion-only result
- exposure
- Dose, timing and assay details for this null result are not separately reported.
- limitations
- These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. No plotted experiment or effect-size interval is provided. Preserve this author-reported null; it is not proof of equivalence.
- organism
- Human experimental cells; construct species unresolved where stated for discussion-only nulls
- primary_locator
- Discussion, page 6
- primary_references
- https://doi.org/10.1016/j.bbrc.2024.150244
- source_access
- Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis.
APT2: sulforaphane engagement, GPX4 stability and ZDHHC6 turnover · lines 52–60
Targeted primary-literature curation from recursive ZDHHC6 exploration, 2026-09-20. · supports · Cell model and construct species not specified for this discussion-only result · source_derived_draft · unverified_draft
The sulforaphane study reports no significant change in GAP-43 palmitoylation in the presence of sulforaphane. primary_references: https://doi.org/10.1016/j.bbrc.2024.150244 primary_locator: Discussion, page 6 source_access: Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis. evidence_cache: artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a experimental_model: Cell model and construct species not specified for this discussion-only result organism: Human experimental cells; construct species unresolved where stated for discussion-only nulls exposure: Dose, timing and assay details for this null result are not separately reported. limitations: These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. No plotted experiment or effect-size interval is provided. Preserve this author-reported null; it is not proof of equivalence.
Complete structured claim and evidenceThe sulforaphane study reports no significant change in H-Ras palmitoylation in the presence of sulforaphane.
Experimental context and source evidence
- evidence_cache
- artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a
- experimental_model
- Cell model and construct species not specified for this discussion-only result
- exposure
- Dose, timing and assay details for this null result are not separately reported.
- limitations
- These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. No plotted experiment or effect-size interval is provided. This limits a universal APT2-substrate prediction.
- organism
- Human experimental cells; construct species unresolved where stated for discussion-only nulls
- primary_locator
- Discussion, page 6
- primary_references
- https://doi.org/10.1016/j.bbrc.2024.150244
- source_access
- Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis.
APT2: sulforaphane engagement, GPX4 stability and ZDHHC6 turnover · lines 63–71
Targeted primary-literature curation from recursive ZDHHC6 exploration, 2026-09-20. · supports · Cell model and construct species not specified for this discussion-only result · source_derived_draft · unverified_draft
The sulforaphane study reports no significant change in H-Ras palmitoylation in the presence of sulforaphane. primary_references: https://doi.org/10.1016/j.bbrc.2024.150244 primary_locator: Discussion, page 6 source_access: Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis. evidence_cache: artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a experimental_model: Cell model and construct species not specified for this discussion-only result organism: Human experimental cells; construct species unresolved where stated for discussion-only nulls exposure: Dose, timing and assay details for this null result are not separately reported. limitations: These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. No plotted experiment or effect-size interval is provided. This limits a universal APT2-substrate prediction.
Complete structured claim and evidence
What acts on it
Interindividual precursor conversion varied over 100-fold in the studied intervention samples despite equivalent administered preparation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"}
- experimental_model
- Isotope-dilution LC-MS/MS assay validation in intervention urines
- exposure
- Broccoli sprout intervention specimens with equivalent administered preparation
- limitations
- Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 98 urine specimens
- plain_language
- The same precursor dose did not produce the same exposure in everyone.
- primary_references
- [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
- tissue_or_cell_type
- Urinary mercapturic-acid pathway species
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 385–396
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isotope-dilution LC-MS/MS assay validation in intervention urines · source_derived_draft · unverified_draft
### sulforaphane-conversion-variability Interindividual precursor conversion varied over 100-fold in the studied intervention samples despite equivalent administered preparation. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The same precursor dose did not produce the same exposure in everyone. organism: Human, 98 urine specimens tissue_or_cell_type: Urinary mercapturic-acid pathway species experimental_model: Isotope-dilution LC-MS/MS assay validation in intervention urines limitations: Analytical exposure study; metabolite concentration is not tissue efficacy and does not identify each responsible human enzyme. exposure: Broccoli sprout intervention specimens with equivalent administered preparation evidence_span: {"source_cache": "artifacts/sulforaphane-research/18729326.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3", "start_char": 0, "end_char": 2172, "text_sha256": "1b30293ede979c158852939b48f68a2cd71fa605bbca813a9fe2325f99e5c1d3"} [sulforaphane-p18729326] Quantification of sulforaphane mercapturic acid pathway conjugates in human urine by high-performance liquid chromatography and isotope-dilution tandem mass spectrometry. (2008). https://pubmed.ncbi.nlm.nih.gov/18729326/ DOI: 10.1021/tx800210k
Complete structured claim and evidenceSulforaphane underwent both nonenzymatic and GST-catalyzed conjugation with glutathione.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/7826396.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe", "start_char": 0, "end_char": 989, "text_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe"}
- experimental_model
- Recombinant human GST conjugation and reverse-reaction kinetics
- exposure
- Four isothiocyanates and GSTP1-1, GSTM1-1, GSTA1-1 and GSTM2-2
- limitations
- Relative enzyme rates are not whole-person clearance predictions; reverse reactions were slower and inhibited by high GSH.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human GST isoenzymes
- plain_language
- Glutathione is a reacting molecule here, not merely an antioxidant label.
- primary_references
- [sulforaphane-p7826396] Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. (1995). https://pubmed.ncbi.nlm.nih.gov/7826396/ DOI: 10.1006/bbrc.1995.1106
- tissue_or_cell_type
- Isothiocyanate-glutathione chemistry
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 281–292
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human GST conjugation and reverse-reaction kinetics · source_derived_draft · unverified_draft
### sulforaphane-gsh-conjugation Sulforaphane underwent both nonenzymatic and GST-catalyzed conjugation with glutathione. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Glutathione is a reacting molecule here, not merely an antioxidant label. organism: Human GST isoenzymes tissue_or_cell_type: Isothiocyanate-glutathione chemistry experimental_model: Recombinant human GST conjugation and reverse-reaction kinetics limitations: Relative enzyme rates are not whole-person clearance predictions; reverse reactions were slower and inhibited by high GSH. exposure: Four isothiocyanates and GSTP1-1, GSTM1-1, GSTA1-1 and GSTM2-2 evidence_span: {"source_cache": "artifacts/sulforaphane-research/7826396.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe", "start_char": 0, "end_char": 989, "text_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe"} [sulforaphane-p7826396] Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. (1995). https://pubmed.ncbi.nlm.nih.gov/7826396/ DOI: 10.1006/bbrc.1995.1106
Complete structured claim and evidenceHeating to 60 degrees C before homogenization reduced ESP activity and nitrile formation while increasing sulforaphane yield.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/15184012.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6", "start_char": 0, "end_char": 1665, "text_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6"}
- experimental_model
- Food processing and enzyme-activity experiments
- exposure
- Heating before homogenization, including 60 and at least 70 degrees C
- limitations
- Time, cultivar, food matrix and enzyme heat sensitivities matter; not a universal cooking prescription.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Broccoli florets and sprouts; mouse hepatoma bioassay
- plain_language
- Mild heating can suppress a competing route before destroying all useful enzyme activity.
- primary_references
- [sulforaphane-p15184012] Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. (2004). https://pubmed.ncbi.nlm.nih.gov/15184012/ DOI: 10.1016/j.phytochem.2004.04.013
- tissue_or_cell_type
- Plant tissue hydrolysis
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 151–162
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Food processing and enzyme-activity experiments · source_derived_draft · unverified_draft
### sulforaphane-heat-esp Heating to 60 degrees C before homogenization reduced ESP activity and nitrile formation while increasing sulforaphane yield. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Mild heating can suppress a competing route before destroying all useful enzyme activity. organism: Broccoli florets and sprouts; mouse hepatoma bioassay tissue_or_cell_type: Plant tissue hydrolysis experimental_model: Food processing and enzyme-activity experiments limitations: Time, cultivar, food matrix and enzyme heat sensitivities matter; not a universal cooking prescription. exposure: Heating before homogenization, including 60 and at least 70 degrees C evidence_span: {"source_cache": "artifacts/sulforaphane-research/15184012.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6", "start_char": 0, "end_char": 1665, "text_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6"} [sulforaphane-p15184012] Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. (2004). https://pubmed.ncbi.nlm.nih.gov/15184012/ DOI: 10.1016/j.phytochem.2004.04.013
Complete structured claim and evidenceHeating broccoli florets to 70 degrees C or above decreased formation of both measured products; the same reduction did not occur in sprouts.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/15184012.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6", "start_char": 0, "end_char": 1665, "text_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6"}
- experimental_model
- Food processing and enzyme-activity experiments
- exposure
- Heating before homogenization, including 60 and at least 70 degrees C
- limitations
- Time, cultivar, food matrix and enzyme heat sensitivities matter; not a universal cooking prescription.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Broccoli florets and sprouts; mouse hepatoma bioassay
- plain_language
- The response to heat depended on which plant material was tested.
- primary_references
- [sulforaphane-p15184012] Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. (2004). https://pubmed.ncbi.nlm.nih.gov/15184012/ DOI: 10.1016/j.phytochem.2004.04.013
- tissue_or_cell_type
- Plant tissue hydrolysis
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 164–175
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Food processing and enzyme-activity experiments · source_derived_draft · unverified_draft
### sulforaphane-hotter-processing Heating broccoli florets to 70 degrees C or above decreased formation of both measured products; the same reduction did not occur in sprouts. Condition category: machinery_impairment nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response to heat depended on which plant material was tested. organism: Broccoli florets and sprouts; mouse hepatoma bioassay tissue_or_cell_type: Plant tissue hydrolysis experimental_model: Food processing and enzyme-activity experiments limitations: Time, cultivar, food matrix and enzyme heat sensitivities matter; not a universal cooking prescription. exposure: Heating before homogenization, including 60 and at least 70 degrees C evidence_span: {"source_cache": "artifacts/sulforaphane-research/15184012.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6", "start_char": 0, "end_char": 1665, "text_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6"} [sulforaphane-p15184012] Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. (2004). https://pubmed.ncbi.nlm.nih.gov/15184012/ DOI: 10.1016/j.phytochem.2004.04.013
Complete structured claim and evidenceMyrosinase hydrolysis of glucoraphanin after broccoli tissue disruption enabled sulforaphane formation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/15184012.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6", "start_char": 0, "end_char": 1665, "text_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6"}
- experimental_model
- Food processing and enzyme-activity experiments
- exposure
- Heating before homogenization, including 60 and at least 70 degrees C
- limitations
- Time, cultivar, food matrix and enzyme heat sensitivities matter; not a universal cooking prescription.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Broccoli florets and sprouts; mouse hepatoma bioassay
- plain_language
- The precursor and plant enzyme must come together before this product is formed.
- primary_references
- [sulforaphane-p15184012] Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. (2004). https://pubmed.ncbi.nlm.nih.gov/15184012/ DOI: 10.1016/j.phytochem.2004.04.013
- tissue_or_cell_type
- Plant tissue hydrolysis
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 138–149
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Food processing and enzyme-activity experiments · source_derived_draft · unverified_draft
### sulforaphane-myrosinase-formation Myrosinase hydrolysis of glucoraphanin after broccoli tissue disruption enabled sulforaphane formation. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The precursor and plant enzyme must come together before this product is formed. organism: Broccoli florets and sprouts; mouse hepatoma bioassay tissue_or_cell_type: Plant tissue hydrolysis experimental_model: Food processing and enzyme-activity experiments limitations: Time, cultivar, food matrix and enzyme heat sensitivities matter; not a universal cooking prescription. exposure: Heating before homogenization, including 60 and at least 70 degrees C evidence_span: {"source_cache": "artifacts/sulforaphane-research/15184012.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6", "start_char": 0, "end_char": 1665, "text_sha256": "3a1b248b03fcfc77ee38ab6b4189c6c565b24f2071912565f0377ce00e8de0e6"} [sulforaphane-p15184012] Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. (2004). https://pubmed.ncbi.nlm.nih.gov/15184012/ DOI: 10.1016/j.phytochem.2004.04.013
Complete structured claim and evidenceGSTs also catalyzed reverse cleavage of isothiocyanate-GSH conjugates; those reactions were slow and inhibited by high GSH.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/7826396.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe", "start_char": 0, "end_char": 989, "text_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe"}
- experimental_model
- Recombinant human GST conjugation and reverse-reaction kinetics
- exposure
- Four isothiocyanates and GSTP1-1, GSTM1-1, GSTA1-1 and GSTM2-2
- limitations
- Relative enzyme rates are not whole-person clearance predictions; reverse reactions were slower and inhibited by high GSH.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human GST isoenzymes
- plain_language
- Conjugation is reversible, so bound and free exposure are related but different.
- primary_references
- [sulforaphane-p7826396] Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. (1995). https://pubmed.ncbi.nlm.nih.gov/7826396/ DOI: 10.1006/bbrc.1995.1106
- tissue_or_cell_type
- Isothiocyanate-glutathione chemistry
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 294–305
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human GST conjugation and reverse-reaction kinetics · source_derived_draft · unverified_draft
### sulforaphane-reverse-conjugation GSTs also catalyzed reverse cleavage of isothiocyanate-GSH conjugates; those reactions were slow and inhibited by high GSH. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Conjugation is reversible, so bound and free exposure are related but different. organism: Human GST isoenzymes tissue_or_cell_type: Isothiocyanate-glutathione chemistry experimental_model: Recombinant human GST conjugation and reverse-reaction kinetics limitations: Relative enzyme rates are not whole-person clearance predictions; reverse reactions were slower and inhibited by high GSH. exposure: Four isothiocyanates and GSTP1-1, GSTM1-1, GSTA1-1 and GSTM2-2 evidence_span: {"source_cache": "artifacts/sulforaphane-research/7826396.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe", "start_char": 0, "end_char": 989, "text_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe"} [sulforaphane-p7826396] Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. (1995). https://pubmed.ncbi.nlm.nih.gov/7826396/ DOI: 10.1006/bbrc.1995.1106
Complete structured claim and evidence
Where it participates (unsigned role)
P-glycoprotein overexpression also implicated ABCB1 in export of intracellular sulforaphane/conjugate pools.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/11988104.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5759bc0af52a1e906602549a3920ebba5641d09b63cc87f0dc61ea8efcb724a9", "start_char": 0, "end_char": 1567, "text_sha256": "5759bc0af52a1e906602549a3920ebba5641d09b63cc87f0dc61ea8efcb724a9"}
- experimental_model
- Transporter-overexpression and temperature/inhibitor experiments
- exposure
- Sulforaphane loading; ABCC1 or ABCB1 expression
- limitations
- Cancer-cell transport experiments; not a measured clinical drug interaction.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HL60 leukemia and 8226 myeloma cells
- plain_language
- The measured pool can be influenced by more than one transporter.
- primary_references
- [sulforaphane-p11988104] High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. (2002). https://pubmed.ncbi.nlm.nih.gov/11988104/ DOI: 10.1042/bj3640301
- tissue_or_cell_type
- Intracellular retention and export
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 320–331
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transporter-overexpression and temperature/inhibitor experiments · source_derived_draft · unverified_draft
### sulforaphane-abcb1-efflux P-glycoprotein overexpression also implicated ABCB1 in export of intracellular sulforaphane/conjugate pools. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The measured pool can be influenced by more than one transporter. organism: Human HL60 leukemia and 8226 myeloma cells tissue_or_cell_type: Intracellular retention and export experimental_model: Transporter-overexpression and temperature/inhibitor experiments limitations: Cancer-cell transport experiments; not a measured clinical drug interaction. exposure: Sulforaphane loading; ABCC1 or ABCB1 expression evidence_span: {"source_cache": "artifacts/sulforaphane-research/11988104.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5759bc0af52a1e906602549a3920ebba5641d09b63cc87f0dc61ea8efcb724a9", "start_char": 0, "end_char": 1567, "text_sha256": "5759bc0af52a1e906602549a3920ebba5641d09b63cc87f0dc61ea8efcb724a9"} [sulforaphane-p11988104] High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. (2002). https://pubmed.ncbi.nlm.nih.gov/11988104/ DOI: 10.1042/bj3640301
Complete structured claim and evidenceMRP1-overexpressing human cells supported rapid export of accumulated sulforaphane, mainly as its glutathione conjugate.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/11988104.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5759bc0af52a1e906602549a3920ebba5641d09b63cc87f0dc61ea8efcb724a9", "start_char": 0, "end_char": 1567, "text_sha256": "5759bc0af52a1e906602549a3920ebba5641d09b63cc87f0dc61ea8efcb724a9"}
- experimental_model
- Transporter-overexpression and temperature/inhibitor experiments
- exposure
- Sulforaphane loading; ABCC1 or ABCB1 expression
- limitations
- Cancer-cell transport experiments; not a measured clinical drug interaction.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HL60 leukemia and 8226 myeloma cells
- plain_language
- A transporter can shorten intracellular exposure.
- primary_references
- [sulforaphane-p11988104] High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. (2002). https://pubmed.ncbi.nlm.nih.gov/11988104/ DOI: 10.1042/bj3640301
- tissue_or_cell_type
- Intracellular retention and export
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 307–318
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transporter-overexpression and temperature/inhibitor experiments · source_derived_draft · unverified_draft
### sulforaphane-abcc1-efflux MRP1-overexpressing human cells supported rapid export of accumulated sulforaphane, mainly as its glutathione conjugate. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: A transporter can shorten intracellular exposure. organism: Human HL60 leukemia and 8226 myeloma cells tissue_or_cell_type: Intracellular retention and export experimental_model: Transporter-overexpression and temperature/inhibitor experiments limitations: Cancer-cell transport experiments; not a measured clinical drug interaction. exposure: Sulforaphane loading; ABCC1 or ABCB1 expression evidence_span: {"source_cache": "artifacts/sulforaphane-research/11988104.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5759bc0af52a1e906602549a3920ebba5641d09b63cc87f0dc61ea8efcb724a9", "start_char": 0, "end_char": 1567, "text_sha256": "5759bc0af52a1e906602549a3920ebba5641d09b63cc87f0dc61ea8efcb724a9"} [sulforaphane-p11988104] High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. (2002). https://pubmed.ncbi.nlm.nih.gov/11988104/ DOI: 10.1042/bj3640301
Complete structured claim and evidenceUrinary acrolein-derived conjugate excretion increased by 23%.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/24913818.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd", "start_char": 0, "end_char": 1710, "text_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd"}
- experimental_model
- Randomized placebo-controlled beverage trial
- exposure
- 600 micromol glucoraphanin plus 40 micromol sulforaphane daily for 12 weeks
- limitations
- Urinary conjugate excretion is not proof of reduced cancer incidence, removal of every toxin or a clinical detoxification indication.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 291 recruited adults in Qidong
- plain_language
- The result extended to a second measured pollutant.
- primary_references
- [sulforaphane-p24913818] Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. (2014). https://pubmed.ncbi.nlm.nih.gov/24913818/ DOI: 10.1158/1940-6207.capr-14-0103
- tissue_or_cell_type
- Urinary pollutant mercapturates
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1061–1072
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled beverage trial · source_derived_draft · unverified_draft
### sulforaphane-acrolein-excretion Urinary acrolein-derived conjugate excretion increased by 23%. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The result extended to a second measured pollutant. organism: Human, 291 recruited adults in Qidong tissue_or_cell_type: Urinary pollutant mercapturates experimental_model: Randomized placebo-controlled beverage trial limitations: Urinary conjugate excretion is not proof of reduced cancer incidence, removal of every toxin or a clinical detoxification indication. exposure: 600 micromol glucoraphanin plus 40 micromol sulforaphane daily for 12 weeks evidence_span: {"source_cache": "artifacts/sulforaphane-research/24913818.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd", "start_char": 0, "end_char": 1710, "text_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd"} [sulforaphane-p24913818] Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. (2014). https://pubmed.ncbi.nlm.nih.gov/24913818/ DOI: 10.1158/1940-6207.capr-14-0103
Complete structured claim and evidenceThe intervention increased urinary benzene-derived conjugate excretion by 61% compared with placebo.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/24913818.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd", "start_char": 0, "end_char": 1710, "text_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd"}
- experimental_model
- Randomized placebo-controlled beverage trial
- exposure
- 600 micromol glucoraphanin plus 40 micromol sulforaphane daily for 12 weeks
- limitations
- Urinary conjugate excretion is not proof of reduced cancer incidence, removal of every toxin or a clinical detoxification indication.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 291 recruited adults in Qidong
- plain_language
- A specific exposure-processing marker increased.
- primary_references
- [sulforaphane-p24913818] Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. (2014). https://pubmed.ncbi.nlm.nih.gov/24913818/ DOI: 10.1158/1940-6207.capr-14-0103
- tissue_or_cell_type
- Urinary pollutant mercapturates
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1048–1059
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled beverage trial · source_derived_draft · unverified_draft
### sulforaphane-benzene-excretion The intervention increased urinary benzene-derived conjugate excretion by 61% compared with placebo. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: A specific exposure-processing marker increased. organism: Human, 291 recruited adults in Qidong tissue_or_cell_type: Urinary pollutant mercapturates experimental_model: Randomized placebo-controlled beverage trial limitations: Urinary conjugate excretion is not proof of reduced cancer incidence, removal of every toxin or a clinical detoxification indication. exposure: 600 micromol glucoraphanin plus 40 micromol sulforaphane daily for 12 weeks evidence_span: {"source_cache": "artifacts/sulforaphane-research/24913818.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd", "start_char": 0, "end_char": 1710, "text_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd"} [sulforaphane-p24913818] Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. (2014). https://pubmed.ncbi.nlm.nih.gov/24913818/ DOI: 10.1158/1940-6207.capr-14-0103
Complete structured claim and evidenceKEAP1 C151S was markedly resistant to sulforaphane inhibition of its Nrf2-ubiquitination function.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/15572695.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765", "start_char": 0, "end_char": 1484, "text_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765"}
- experimental_model
- Cell transfection, coimmunoprecipitation and ubiquitination assays
- exposure
- Sulforaphane or quinone stress; C151S KEAP1 comparison
- limitations
- The measured interaction is ubiquitin-ligase regulation; do not describe it as obligatory physical release of all bound Nrf2.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human protein constructs in mammalian cell systems
- plain_language
- An altered sensor can block the response even when the compound is present.
- primary_references
- [sulforaphane-p15572695] Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. (2004). https://pubmed.ncbi.nlm.nih.gov/15572695/ DOI: 10.1128/mcb.24.24.10941-10953.2004
- tissue_or_cell_type
- KEAP1-CUL3-RBX1 control of Nrf2
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 502–513
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell transfection, coimmunoprecipitation and ubiquitination assays · source_derived_draft · unverified_draft
### sulforaphane-c151s-response KEAP1 C151S was markedly resistant to sulforaphane inhibition of its Nrf2-ubiquitination function. Condition category: machinery_impairment nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: An altered sensor can block the response even when the compound is present. organism: Human protein constructs in mammalian cell systems tissue_or_cell_type: KEAP1-CUL3-RBX1 control of Nrf2 experimental_model: Cell transfection, coimmunoprecipitation and ubiquitination assays limitations: The measured interaction is ubiquitin-ligase regulation; do not describe it as obligatory physical release of all bound Nrf2. exposure: Sulforaphane or quinone stress; C151S KEAP1 comparison evidence_span: {"source_cache": "artifacts/sulforaphane-research/15572695.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765", "start_char": 0, "end_char": 1484, "text_sha256": "d120b0ea48a77a99b12e9147e4acb02fd63026ed729a37d5e2edf174c5674765"} [sulforaphane-p15572695] Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. (2004). https://pubmed.ncbi.nlm.nih.gov/15572695/ DOI: 10.1128/mcb.24.24.10941-10953.2004
Complete structured claim and evidenceCrotonaldehyde-derived conjugate excretion did not show the intervention increase observed for benzene and acrolein.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/24913818.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd", "start_char": 0, "end_char": 1710, "text_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd"}
- experimental_model
- Randomized placebo-controlled beverage trial
- exposure
- 600 micromol glucoraphanin plus 40 micromol sulforaphane daily for 12 weeks
- limitations
- Urinary conjugate excretion is not proof of reduced cancer incidence, removal of every toxin or a clinical detoxification indication.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human, 291 recruited adults in Qidong
- plain_language
- The response was selective rather than a universal detoxification boost.
- primary_references
- [sulforaphane-p24913818] Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. (2014). https://pubmed.ncbi.nlm.nih.gov/24913818/ DOI: 10.1158/1940-6207.capr-14-0103
- tissue_or_cell_type
- Urinary pollutant mercapturates
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1074–1085
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized placebo-controlled beverage trial · source_derived_draft · unverified_draft
### sulforaphane-crotonaldehyde-null Crotonaldehyde-derived conjugate excretion did not show the intervention increase observed for benzene and acrolein. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The response was selective rather than a universal detoxification boost. organism: Human, 291 recruited adults in Qidong tissue_or_cell_type: Urinary pollutant mercapturates experimental_model: Randomized placebo-controlled beverage trial limitations: Urinary conjugate excretion is not proof of reduced cancer incidence, removal of every toxin or a clinical detoxification indication. exposure: 600 micromol glucoraphanin plus 40 micromol sulforaphane daily for 12 weeks evidence_span: {"source_cache": "artifacts/sulforaphane-research/24913818.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd", "start_char": 0, "end_char": 1710, "text_sha256": "dabcc8a48260f668232ae3ab528fbf08e7b8b814ad9959d709fcd4702bbda7dd"} [sulforaphane-p24913818] Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. (2014). https://pubmed.ncbi.nlm.nih.gov/24913818/ DOI: 10.1158/1940-6207.capr-14-0103
Complete structured claim and evidenceConcentrated broccoli sprout extract lowered fasting glucose in obese patients with dysregulated type 2 diabetes in the reported subgroup.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"}
- experimental_model
- Network-guided preclinical work with a human intervention
- exposure
- Concentrated broccoli sprout extract; obese dysregulated-diabetes subgroup
- limitations
- Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Hepatic cell/animal models and humans with type 2 diabetes
- plain_language
- The clinical response depended on the studied metabolic population.
- primary_references
- [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
- tissue_or_cell_type
- Glucose production and clinical glucose control
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1152–1163
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Network-guided preclinical work with a human intervention · source_derived_draft · unverified_draft
### sulforaphane-diabetes-glucose Concentrated broccoli sprout extract lowered fasting glucose in obese patients with dysregulated type 2 diabetes in the reported subgroup. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The clinical response depended on the studied metabolic population. organism: Hepatic cell/animal models and humans with type 2 diabetes tissue_or_cell_type: Glucose production and clinical glucose control experimental_model: Network-guided preclinical work with a human intervention limitations: Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed. exposure: Concentrated broccoli sprout extract; obese dysregulated-diabetes subgroup evidence_span: {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"} [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
Complete structured claim and evidenceHbA1c decreased in the reported obese dysregulated-diabetes subgroup.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"}
- experimental_model
- Network-guided preclinical work with a human intervention
- exposure
- Concentrated broccoli sprout extract; obese dysregulated-diabetes subgroup
- limitations
- Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Hepatic cell/animal models and humans with type 2 diabetes
- plain_language
- A longer-term glucose marker also changed in that subgroup.
- primary_references
- [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
- tissue_or_cell_type
- Glucose production and clinical glucose control
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1165–1176
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Network-guided preclinical work with a human intervention · source_derived_draft · unverified_draft
### sulforaphane-diabetes-hba1c HbA1c decreased in the reported obese dysregulated-diabetes subgroup. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: A longer-term glucose marker also changed in that subgroup. organism: Hepatic cell/animal models and humans with type 2 diabetes tissue_or_cell_type: Glucose production and clinical glucose control experimental_model: Network-guided preclinical work with a human intervention limitations: Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed. exposure: Concentrated broccoli sprout extract; obese dysregulated-diabetes subgroup evidence_span: {"source_cache": "artifacts/sulforaphane-research/28615356.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e", "start_char": 0, "end_char": 1106, "text_sha256": "65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e"} [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477
Complete structured claim and evidenceRecombinant broccoli ESP redirected myrosinase-dependent glucoraphanin hydrolysis toward sulforaphane nitrile rather than sulforaphane.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/16536577.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e3636614520a0c9f83132284992ffc10ca42943f97619933f8009ceb697ddfa9", "start_char": 0, "end_char": 1301, "text_sha256": "e3636614520a0c9f83132284992ffc10ca42943f97619933f8009ceb697ddfa9"}
- experimental_model
- Recombinant protein and glucosinolate product analysis
- exposure
- Purified recombinant ESP in a model hydrolysis system
- limitations
- Plant chemistry; does not establish a human health effect of the nitrile product.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Broccoli cv. Packman ESP expressed in E. coli
- plain_language
- A second plant protein changes which molecule is produced.
- primary_references
- [sulforaphane-p16536577] Epithiospecifier protein from broccoli (Brassica oleracea L. ssp. italica) inhibits formation of the anticancer agent sulforaphane. (2006). https://pubmed.ncbi.nlm.nih.gov/16536577/ DOI: 10.1021/jf0525277
- tissue_or_cell_type
- Myrosinase-dependent glucoraphanin conversion
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 177–188
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant protein and glucosinolate product analysis · source_derived_draft · unverified_draft
### sulforaphane-esp-nitrile Recombinant broccoli ESP redirected myrosinase-dependent glucoraphanin hydrolysis toward sulforaphane nitrile rather than sulforaphane. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: A second plant protein changes which molecule is produced. organism: Broccoli cv. Packman ESP expressed in E. coli tissue_or_cell_type: Myrosinase-dependent glucoraphanin conversion experimental_model: Recombinant protein and glucosinolate product analysis limitations: Plant chemistry; does not establish a human health effect of the nitrile product. exposure: Purified recombinant ESP in a model hydrolysis system evidence_span: {"source_cache": "artifacts/sulforaphane-research/16536577.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e3636614520a0c9f83132284992ffc10ca42943f97619933f8009ceb697ddfa9", "start_char": 0, "end_char": 1301, "text_sha256": "e3636614520a0c9f83132284992ffc10ca42943f97619933f8009ceb697ddfa9"} [sulforaphane-p16536577] Epithiospecifier protein from broccoli (Brassica oleracea L. ssp. italica) inhibits formation of the anticancer agent sulforaphane. (2006). https://pubmed.ncbi.nlm.nih.gov/16536577/ DOI: 10.1021/jf0525277
Complete structured claim and evidenceBSO pretreatment significantly reduced sulforaphane-induced TXNRD1 mRNA.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"}
- experimental_model
- Transcription/translation and inhibitor experiments
- exposure
- Sulforaphane, sodium selenite, combined treatment and pathway inhibitors
- limitations
- Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HepG2 hepatoma cells
- plain_language
- The signaling response depended on the surrounding glutathione system.
- primary_references
- [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
- tissue_or_cell_type
- Thioredoxin reductase regulation
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 762–773
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transcription/translation and inhibitor experiments · source_derived_draft · unverified_draft
### sulforaphane-gsh-gates-induction BSO pretreatment significantly reduced sulforaphane-induced TXNRD1 mRNA. Condition category: machinery_impairment nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The signaling response depended on the surrounding glutathione system. organism: Human HepG2 hepatoma cells tissue_or_cell_type: Thioredoxin reductase regulation experimental_model: Transcription/translation and inhibitor experiments limitations: Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable. exposure: Sulforaphane, sodium selenite, combined treatment and pathway inhibitors evidence_span: {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"} [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
Complete structured claim and evidenceGSTM1-1 was among the efficient tested human GST catalysts for isothiocyanate conjugation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/7826396.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe", "start_char": 0, "end_char": 989, "text_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe"}
- experimental_model
- Recombinant human GST conjugation and reverse-reaction kinetics
- exposure
- Four isothiocyanates and GSTP1-1, GSTM1-1, GSTA1-1 and GSTM2-2
- limitations
- Relative enzyme rates are not whole-person clearance predictions; reverse reactions were slower and inhibited by high GSH.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human GST isoenzymes
- plain_language
- Different GST isoenzymes can participate in this route.
- primary_references
- [sulforaphane-p7826396] Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. (1995). https://pubmed.ncbi.nlm.nih.gov/7826396/ DOI: 10.1006/bbrc.1995.1106
- tissue_or_cell_type
- Isothiocyanate-glutathione chemistry
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 268–279
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human GST conjugation and reverse-reaction kinetics · source_derived_draft · unverified_draft
### sulforaphane-gstm-conjugation GSTM1-1 was among the efficient tested human GST catalysts for isothiocyanate conjugation. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Different GST isoenzymes can participate in this route. organism: Human GST isoenzymes tissue_or_cell_type: Isothiocyanate-glutathione chemistry experimental_model: Recombinant human GST conjugation and reverse-reaction kinetics limitations: Relative enzyme rates are not whole-person clearance predictions; reverse reactions were slower and inhibited by high GSH. exposure: Four isothiocyanates and GSTP1-1, GSTM1-1, GSTA1-1 and GSTM2-2 evidence_span: {"source_cache": "artifacts/sulforaphane-research/7826396.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe", "start_char": 0, "end_char": 989, "text_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe"} [sulforaphane-p7826396] Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. (1995). https://pubmed.ncbi.nlm.nih.gov/7826396/ DOI: 10.1006/bbrc.1995.1106
Complete structured claim and evidenceGSTP1-1 catalyzed sulforaphane conjugation with glutathione in the human enzyme comparison.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/7826396.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe", "start_char": 0, "end_char": 989, "text_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe"}
- experimental_model
- Recombinant human GST conjugation and reverse-reaction kinetics
- exposure
- Four isothiocyanates and GSTP1-1, GSTM1-1, GSTA1-1 and GSTM2-2
- limitations
- Relative enzyme rates are not whole-person clearance predictions; reverse reactions were slower and inhibited by high GSH.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human GST isoenzymes
- plain_language
- Glutathione attaches to sulforaphane during its handling.
- primary_references
- [sulforaphane-p7826396] Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. (1995). https://pubmed.ncbi.nlm.nih.gov/7826396/ DOI: 10.1006/bbrc.1995.1106
- tissue_or_cell_type
- Isothiocyanate-glutathione chemistry
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 255–266
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human GST conjugation and reverse-reaction kinetics · source_derived_draft · unverified_draft
### sulforaphane-gstp-conjugation GSTP1-1 catalyzed sulforaphane conjugation with glutathione in the human enzyme comparison. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Glutathione attaches to sulforaphane during its handling. organism: Human GST isoenzymes tissue_or_cell_type: Isothiocyanate-glutathione chemistry experimental_model: Recombinant human GST conjugation and reverse-reaction kinetics limitations: Relative enzyme rates are not whole-person clearance predictions; reverse reactions were slower and inhibited by high GSH. exposure: Four isothiocyanates and GSTP1-1, GSTM1-1, GSTA1-1 and GSTM2-2 evidence_span: {"source_cache": "artifacts/sulforaphane-research/7826396.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe", "start_char": 0, "end_char": 989, "text_sha256": "5dee3c3a8c8069c33fac2653f16f3521cdd17ef5e8ebddd0f82cfa3a5c95c0fe"} [sulforaphane-p7826396] Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. (1995). https://pubmed.ncbi.nlm.nih.gov/7826396/ DOI: 10.1006/bbrc.1995.1106
Complete structured claim and evidenceGSTP1-1 expression alone accelerated sulforaphane/conjugate accumulation and increased ARE reporter induction.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/18204073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9", "start_char": 0, "end_char": 1894, "text_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9"}
- experimental_model
- Transgenic transporter/enzyme comparison
- exposure
- Sulforaphane; GSH depletion control
- limitations
- Engineered cancer cells; enzyme expression and efflux can have opposing effects without being a scientific contradiction.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MCF7 cells with GSTP1 and/or MRP1
- plain_language
- Conjugation can initially retain the exposure inside cells.
- primary_references
- [sulforaphane-p18204073] Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane. (2008). https://pubmed.ncbi.nlm.nih.gov/18204073/ DOI: 10.1093/carcin/bgn013
- tissue_or_cell_type
- Intracellular retention, ARE induction and Nrf2 persistence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1009–1020
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transgenic transporter/enzyme comparison · source_derived_draft · unverified_draft
### sulforaphane-gstp-retention GSTP1-1 expression alone accelerated sulforaphane/conjugate accumulation and increased ARE reporter induction. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Conjugation can initially retain the exposure inside cells. organism: Human MCF7 cells with GSTP1 and/or MRP1 tissue_or_cell_type: Intracellular retention, ARE induction and Nrf2 persistence experimental_model: Transgenic transporter/enzyme comparison limitations: Engineered cancer cells; enzyme expression and efflux can have opposing effects without being a scientific contradiction. exposure: Sulforaphane; GSH depletion control evidence_span: {"source_cache": "artifacts/sulforaphane-research/18204073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9", "start_char": 0, "end_char": 1894, "text_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9"} [sulforaphane-p18204073] Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane. (2008). https://pubmed.ncbi.nlm.nih.gov/18204073/ DOI: 10.1093/carcin/bgn013
Complete structured claim and evidenceThe sulforaphane-induced Nrf2 increase was less sustained in MRP1-expressing cells, especially with GSTP1 coexpression.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/18204073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9", "start_char": 0, "end_char": 1894, "text_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9"}
- experimental_model
- Transgenic transporter/enzyme comparison
- exposure
- Sulforaphane; GSH depletion control
- limitations
- Engineered cancer cells; enzyme expression and efflux can have opposing effects without being a scientific contradiction.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MCF7 cells with GSTP1 and/or MRP1
- plain_language
- The duration of the response depends partly on how the compound is handled.
- primary_references
- [sulforaphane-p18204073] Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane. (2008). https://pubmed.ncbi.nlm.nih.gov/18204073/ DOI: 10.1093/carcin/bgn013
- tissue_or_cell_type
- Intracellular retention, ARE induction and Nrf2 persistence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1035–1046
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transgenic transporter/enzyme comparison · source_derived_draft · unverified_draft
### sulforaphane-mrp-nrf2-duration The sulforaphane-induced Nrf2 increase was less sustained in MRP1-expressing cells, especially with GSTP1 coexpression. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The duration of the response depends partly on how the compound is handled. organism: Human MCF7 cells with GSTP1 and/or MRP1 tissue_or_cell_type: Intracellular retention, ARE induction and Nrf2 persistence experimental_model: Transgenic transporter/enzyme comparison limitations: Engineered cancer cells; enzyme expression and efflux can have opposing effects without being a scientific contradiction. exposure: Sulforaphane; GSH depletion control evidence_span: {"source_cache": "artifacts/sulforaphane-research/18204073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9", "start_char": 0, "end_char": 1894, "text_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9"} [sulforaphane-p18204073] Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane. (2008). https://pubmed.ncbi.nlm.nih.gov/18204073/ DOI: 10.1093/carcin/bgn013
Complete structured claim and evidenceMRP1 expression reduced intracellular sulforaphane/conjugate accumulation and attenuated ARE-dependent responses.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/18204073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9", "start_char": 0, "end_char": 1894, "text_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9"}
- experimental_model
- Transgenic transporter/enzyme comparison
- exposure
- Sulforaphane; GSH depletion control
- limitations
- Engineered cancer cells; enzyme expression and efflux can have opposing effects without being a scientific contradiction.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human MCF7 cells with GSTP1 and/or MRP1
- plain_language
- Export can counter the retention effect.
- primary_references
- [sulforaphane-p18204073] Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane. (2008). https://pubmed.ncbi.nlm.nih.gov/18204073/ DOI: 10.1093/carcin/bgn013
- tissue_or_cell_type
- Intracellular retention, ARE induction and Nrf2 persistence
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 1022–1033
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transgenic transporter/enzyme comparison · source_derived_draft · unverified_draft
### sulforaphane-mrp-retention MRP1 expression reduced intracellular sulforaphane/conjugate accumulation and attenuated ARE-dependent responses. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Export can counter the retention effect. organism: Human MCF7 cells with GSTP1 and/or MRP1 tissue_or_cell_type: Intracellular retention, ARE induction and Nrf2 persistence experimental_model: Transgenic transporter/enzyme comparison limitations: Engineered cancer cells; enzyme expression and efflux can have opposing effects without being a scientific contradiction. exposure: Sulforaphane; GSH depletion control evidence_span: {"source_cache": "artifacts/sulforaphane-research/18204073.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9", "start_char": 0, "end_char": 1894, "text_sha256": "0fcd98974f9fe12b2ca7c4326f94eddf4f20de4ac2ae6fdebb64de0efb1d8be9"} [sulforaphane-p18204073] Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane. (2008). https://pubmed.ncbi.nlm.nih.gov/18204073/ DOI: 10.1093/carcin/bgn013
Complete structured claim and evidenceCombined sulforaphane and selenite protected HepG2 cells against paraquat-induced death, whereas either alone had little or no protection.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"}
- experimental_model
- Transcription/translation and inhibitor experiments
- exposure
- Sulforaphane, sodium selenite, combined treatment and pathway inhibitors
- limitations
- Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HepG2 hepatoma cells
- plain_language
- A measured combination effect occurred in this specific injury model.
- primary_references
- [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
- tissue_or_cell_type
- Thioredoxin reductase regulation
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 749–760
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transcription/translation and inhibitor experiments · source_derived_draft · unverified_draft
### sulforaphane-paraquat-protection Combined sulforaphane and selenite protected HepG2 cells against paraquat-induced death, whereas either alone had little or no protection. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: A measured combination effect occurred in this specific injury model. organism: Human HepG2 hepatoma cells tissue_or_cell_type: Thioredoxin reductase regulation experimental_model: Transcription/translation and inhibitor experiments limitations: Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable. exposure: Sulforaphane, sodium selenite, combined treatment and pathway inhibitors evidence_span: {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"} [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
Complete structured claim and evidenceSelenite delayed degradation of sulforaphane-induced TXNRD1 mRNA.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"}
- experimental_model
- Transcription/translation and inhibitor experiments
- exposure
- Sulforaphane, sodium selenite, combined treatment and pathway inhibitors
- limitations
- Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HepG2 hepatoma cells
- plain_language
- The message could persist longer when both influences were present.
- primary_references
- [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
- tissue_or_cell_type
- Thioredoxin reductase regulation
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 723–734
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transcription/translation and inhibitor experiments · source_derived_draft · unverified_draft
### sulforaphane-selenite-mrna-stability Selenite delayed degradation of sulforaphane-induced TXNRD1 mRNA. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: The message could persist longer when both influences were present. organism: Human HepG2 hepatoma cells tissue_or_cell_type: Thioredoxin reductase regulation experimental_model: Transcription/translation and inhibitor experiments limitations: Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable. exposure: Sulforaphane, sodium selenite, combined treatment and pathway inhibitors evidence_span: {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"} [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
Complete structured claim and evidenceSelenite increased TXNRD1 protein 2.1-fold and activity 4.8-fold without increasing its mRNA.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"}
- experimental_model
- Transcription/translation and inhibitor experiments
- exposure
- Sulforaphane, sodium selenite, combined treatment and pathway inhibitors
- limitations
- Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HepG2 hepatoma cells
- plain_language
- Selenium supported an increase at the protein-production level.
- primary_references
- [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
- tissue_or_cell_type
- Thioredoxin reductase regulation
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 710–721
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transcription/translation and inhibitor experiments · source_derived_draft · unverified_draft
### sulforaphane-selenite-translation Selenite increased TXNRD1 protein 2.1-fold and activity 4.8-fold without increasing its mRNA. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Selenium supported an increase at the protein-production level. organism: Human HepG2 hepatoma cells tissue_or_cell_type: Thioredoxin reductase regulation experimental_model: Transcription/translation and inhibitor experiments limitations: Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable. exposure: Sulforaphane, sodium selenite, combined treatment and pathway inhibitors evidence_span: {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"} [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
Complete structured claim and evidenceCombined treatment increased TXNRD1 protein 5.5-fold, activity 13-fold and mRNA 6.5-fold in HepG2 cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"}
- experimental_model
- Transcription/translation and inhibitor experiments
- exposure
- Sulforaphane, sodium selenite, combined treatment and pathway inhibitors
- limitations
- Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable.
- nutrient_topic
- Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. · Sulforaphane / SFN, stereochemistry specified per study
- organism
- Human HepG2 hepatoma cells
- plain_language
- Gene expression and enzyme production can combine to produce a larger response.
- primary_references
- [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
- tissue_or_cell_type
- Thioredoxin reductase regulation
Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17) · lines 736–747
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transcription/translation and inhibitor experiments · source_derived_draft · unverified_draft
### sulforaphane-selenium-sfn-synergy Combined treatment increased TXNRD1 protein 5.5-fold, activity 13-fold and mRNA 6.5-fold in HepG2 cells. Condition category: normal nutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect. plain_language: Gene expression and enzyme production can combine to produce a larger response. organism: Human HepG2 hepatoma cells tissue_or_cell_type: Thioredoxin reductase regulation experimental_model: Transcription/translation and inhibitor experiments limitations: Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable. exposure: Sulforaphane, sodium selenite, combined treatment and pathway inhibitors evidence_span: {"source_cache": "artifacts/sulforaphane-research/12663510.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9", "start_char": 0, "end_char": 1535, "text_sha256": "95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9"} [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497
Complete structured claim and evidenceThe sulforaphane-derived activity-based probe captured STAT3 from BB3RC61 cells.
Experimental context and source evidence
- experimental_model
- Human antiestrogen-resistant metastatic breast cancer sample BB3RC61
- exposure
- 5 micromolar SFN-ABP for 30 minutes at 37 C in serum-free DMEM; click chemistry and avidin enrichment followed by anti-STAT3 immunoblot.
- limitations
- The chemical probe and stabilized formulation are separate experimental actors. Capture supports engagement but does not identify the modified STAT3 cysteine or demonstrate that APT2 mediates the effect. No GPX4 time-course endpoint. Primary cell/PDX studies are not evidence of benefit from dietary broccoli.
- organism
- Human
- primary_locator
- Figure 4e; Supplementary Methods: Affinity pull-down assays.
- primary_references
- https://doi.org/10.1038/s41388-020-1335-z
APT2-STAT3 cycling and a competing sulforaphane target route · lines 87–93
Selected primary observations: 10.1038/s41586-020-2799-2 and 10.1038/s41388-020-1335-z. · supports · Human antiestrogen-resistant metastatic breast cancer sample BB3RC61 · source_derived_draft · unverified_draft
The sulforaphane-derived activity-based probe captured STAT3 from BB3RC61 cells. primary_references: https://doi.org/10.1038/s41388-020-1335-z primary_locator: Figure 4e; Supplementary Methods: Affinity pull-down assays. organism: Human experimental_model: Human antiestrogen-resistant metastatic breast cancer sample BB3RC61 exposure: 5 micromolar SFN-ABP for 30 minutes at 37 C in serum-free DMEM; click chemistry and avidin enrichment followed by anti-STAT3 immunoblot. limitations: The chemical probe and stabilized formulation are separate experimental actors. Capture supports engagement but does not identify the modified STAT3 cysteine or demonstrate that APT2 mediates the effect. No GPX4 time-course endpoint. Primary cell/PDX studies are not evidence of benefit from dietary broccoli.
Complete structured claim and evidenceThe sulforaphane-derived activity-based probe captured STAT3 from HBCX34 cells.
Experimental context and source evidence
- experimental_model
- Human HBCx34 breast cancer patient-derived xenograft tumor cells
- exposure
- 5 micromolar SFN-ABP for 30 minutes at 37 C in serum-free DMEM; click chemistry and avidin enrichment followed by anti-STAT3 immunoblot.
- limitations
- The chemical probe and stabilized formulation are separate experimental actors. Capture supports engagement but does not identify the modified STAT3 cysteine or demonstrate that APT2 mediates the effect. No GPX4 time-course endpoint. Primary cell/PDX studies are not evidence of benefit from dietary broccoli.
- organism
- Human
- primary_locator
- Figure 4c; Supplementary Methods: Affinity pull-down assays.
- primary_references
- https://doi.org/10.1038/s41388-020-1335-z
APT2-STAT3 cycling and a competing sulforaphane target route · lines 78–84
Selected primary observations: 10.1038/s41586-020-2799-2 and 10.1038/s41388-020-1335-z. · supports · Human HBCx34 breast cancer patient-derived xenograft tumor cells · source_derived_draft · unverified_draft
The sulforaphane-derived activity-based probe captured STAT3 from HBCX34 cells. primary_references: https://doi.org/10.1038/s41388-020-1335-z primary_locator: Figure 4c; Supplementary Methods: Affinity pull-down assays. organism: Human experimental_model: Human HBCx34 breast cancer patient-derived xenograft tumor cells exposure: 5 micromolar SFN-ABP for 30 minutes at 37 C in serum-free DMEM; click chemistry and avidin enrichment followed by anti-STAT3 immunoblot. limitations: The chemical probe and stabilized formulation are separate experimental actors. Capture supports engagement but does not identify the modified STAT3 cysteine or demonstrate that APT2 mediates the effect. No GPX4 time-course endpoint. Primary cell/PDX studies are not evidence of benefit from dietary broccoli.
Complete structured claim and evidenceSFX-01 reduced phosphorylated STAT3 relative to antiestrogen-only treatments in BB3RC61 cells.
Experimental context and source evidence
- experimental_model
- Human antiestrogen-resistant metastatic breast cancer sample BB3RC61
- exposure
- 72-hour treatment. Supplementary reagent protocol uses 5 micromolar SFX-01, 1 micromolar 4-OH-tamoxifen or 0.1 micromolar fulvestrant; these concentrations are explicitly stated for cell lines, and patient-specific dosing is not independently confirmed here.
- limitations
- The chemical probe and stabilized formulation are separate experimental actors. Capture supports engagement but does not identify the modified STAT3 cysteine or demonstrate that APT2 mediates the effect. No GPX4 time-course endpoint. Primary cell/PDX studies are not evidence of benefit from dietary broccoli.
- organism
- Human
- primary_locator
- Figure 4d; Results: SFX-01 targets STAT3 signaling.
- primary_references
- https://doi.org/10.1038/s41388-020-1335-z
APT2-STAT3 cycling and a competing sulforaphane target route · lines 96–102
Selected primary observations: 10.1038/s41586-020-2799-2 and 10.1038/s41388-020-1335-z. · supports · Human antiestrogen-resistant metastatic breast cancer sample BB3RC61 · source_derived_draft · unverified_draft
SFX-01 reduced phosphorylated STAT3 relative to antiestrogen-only treatments in BB3RC61 cells. primary_references: https://doi.org/10.1038/s41388-020-1335-z primary_locator: Figure 4d; Results: SFX-01 targets STAT3 signaling. organism: Human experimental_model: Human antiestrogen-resistant metastatic breast cancer sample BB3RC61 exposure: 72-hour treatment. Supplementary reagent protocol uses 5 micromolar SFX-01, 1 micromolar 4-OH-tamoxifen or 0.1 micromolar fulvestrant; these concentrations are explicitly stated for cell lines, and patient-specific dosing is not independently confirmed here. limitations: The chemical probe and stabilized formulation are separate experimental actors. Capture supports engagement but does not identify the modified STAT3 cysteine or demonstrate that APT2 mediates the effect. No GPX4 time-course endpoint. Primary cell/PDX studies are not evidence of benefit from dietary broccoli.
Complete structured claim and evidenceSFX-01 did not repress STAT3 activity in the reported previously SFX-01-treated, resistant BB7121 sample.
Experimental context and source evidence
- experimental_model
- Human metastatic breast cancer patient-derived sample BB7121
- exposure
- Prior clinical SFX-01 exposure with progression; ex vivo STAT3 assay. Exact panel exposure unresolved.
- limitations
- The chemical probe and stabilized formulation are separate experimental actors. Capture supports engagement but does not identify the modified STAT3 cysteine or demonstrate that APT2 mediates the effect. No GPX4 time-course endpoint. Primary cell/PDX studies are not evidence of benefit from dietary broccoli. A single resistant sample does not determine the mechanism of resistance. Supplementary legend/main-text result reviewed; raw image not quantitatively reanalyzed.
- organism
- Human
- primary_locator
- Results: SFX-01 targets STAT3 signaling; Supplementary Figure S4c.
- primary_references
- https://doi.org/10.1038/s41388-020-1335-z
APT2-STAT3 cycling and a competing sulforaphane target route · lines 105–111
Selected primary observations: 10.1038/s41586-020-2799-2 and 10.1038/s41388-020-1335-z. · supports · Human metastatic breast cancer patient-derived sample BB7121 · source_derived_draft · unverified_draft
SFX-01 did not repress STAT3 activity in the reported previously SFX-01-treated, resistant BB7121 sample. primary_references: https://doi.org/10.1038/s41388-020-1335-z primary_locator: Results: SFX-01 targets STAT3 signaling; Supplementary Figure S4c. organism: Human experimental_model: Human metastatic breast cancer patient-derived sample BB7121 exposure: Prior clinical SFX-01 exposure with progression; ex vivo STAT3 assay. Exact panel exposure unresolved. limitations: The chemical probe and stabilized formulation are separate experimental actors. Capture supports engagement but does not identify the modified STAT3 cysteine or demonstrate that APT2 mediates the effect. No GPX4 time-course endpoint. Primary cell/PDX studies are not evidence of benefit from dietary broccoli. A single resistant sample does not determine the mechanism of resistance. Supplementary legend/main-text result reviewed; raw image not quantitatively reanalyzed.
Complete structured claim and evidenceSulforaphane did not significantly attenuate Alk14 labeling of APT2-C56S under the conditions that reduced labeling of wild-type APT2.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_cache
- artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a
- experimental_model
- Human HEK293 expressing FLAG-tagged APT2-C56S
- exposure
- 100 micromolar sulforaphane for 3 hours followed by 50 micromolar Alk14 for 5 hours; three separate experiments.
- limitations
- These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. C56S is a mutant-plus-exposure actor. Its baseline function must be assessed before using it as a selective pharmacological rescue.
- organism
- Human experimental cells; construct species unresolved where stated for discussion-only nulls
- primary_locator
- Figure 4C
- primary_references
- https://doi.org/10.1016/j.bbrc.2024.150244
- source_access
- Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis.
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
APT2: sulforaphane engagement, GPX4 stability and ZDHHC6 turnover · lines 41–49
Targeted primary-literature curation from recursive ZDHHC6 exploration, 2026-09-20. · supports · Human HEK293 expressing FLAG-tagged APT2-C56S · source_derived_draft · unverified_draft
Sulforaphane did not significantly attenuate Alk14 labeling of APT2-C56S under the conditions that reduced labeling of wild-type APT2. primary_references: https://doi.org/10.1016/j.bbrc.2024.150244 primary_locator: Figure 4C source_access: Full six-page primary PDF, methods and discussion read; Figure 4 visually inspected. No raw-data reanalysis. evidence_cache: artifacts/discovery-research/round6-sources/sulforaphane-apt2.pdf; SHA256 31e2993f88fe05eec199b9013173b29379b3346b9696ac766771173ddd0f181a experimental_model: Human HEK293 expressing FLAG-tagged APT2-C56S organism: Human experimental cells; construct species unresolved where stated for discussion-only nulls exposure: 100 micromolar sulforaphane for 3 hours followed by 50 micromolar Alk14 for 5 hours; three separate experiments. limitations: These are separate experimental observations, not a demonstrated sulforaphane-GPX4-ZDHHC6 pathway. Sulforaphane-driven APT2 relocalization is not equivalent to genetic depletion or general catalytic inhibition. No dietary, clinical or selenium-repletion effect is inferred. Protein stability, palmitoylation and substrate output remain different measurements. C56S is a mutant-plus-exposure actor. Its baseline function must be assessed before using it as a selective pharmacological rescue.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.